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ABSTRACT

Worldwide, millions of young and elderly patients receive procedures that could
not be performed without the use of anesthetics. Unfortunately, emerging animal and
human data suggest an association between exposure to general anesthesia and
impairment of cognitive function in pediatric and geriatric patients. Recent laboratory
data have shown that general anesthetics are potentially damaging to the developing and
aging brain. However, the mechanism by which this happens is still unknown. General
anesthetics affect learning and memory, a brain function involving neural plasticity. An
important form of neural plasticity receiving attention is postnatal neurogenesis. This
process is highly regulated and involved in hippocampal functions under physiological
conditions. This dissertation hypothesizes that anesthetic induced alteration of postnatal
neurogenesis may explain the cognitive impairment observed in some pediatric and
geriatric patients after anesthesia. In order to accurately address this hypothesis, in the
first portion of this dissertation, an animal model is used to examine the effects of two
different anesthetics on cognition and new cell proliferation in young and aged rats.
Furthermore, the second and third portion of this dissertation emphasizes on the effects of
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these two widely used anesthetics on each of the various stage of postnatal neurogenesis
in young and aged rats.

viii

INTRODUCTION
Thousands of surgeries requiring anesthesia are performed every day in the
United States. Anesthetics are among the most potent and rapidly acting drugs in
common clinical use, and one of the greatest advances of medicine allowing complicated
surgeries to be performed safely. Unfortunately, recent clinical and animal studies show
that exposure to commonly used general anesthetics is associated to the development of
cognitive impairment in pediatric (Loepke and Soriano 2008; Wilder et al. 2009) and
geriatric patients (Moller et al. 1998a; Monk et al. 2008).
The brain appears to be particularly vulnerable to insults that would go unnoticed at a
different age, during development or aging. These insults may become evident as
impairment of cognitive function. Cognitive changes associated with general anesthesia
include impaired spatial orientation, learning and memory, but the mechanism by which
this happens still not known. Spatial learning and memory are considered hippocampal
cognitive domains, although other brain areas may contribute as well. An important
determinant of hippocampal function is the degree to which new neurons are generated
from stem cells in the subgranular zone of the dentate gyrus (DG) of the hippocampus
(Kempermann 2002; Zhao et al. 2008; Jessberger et al. 2009; Coras et al. 2010).
Furthermore, postnatal hippocampal neurogenesis has been shown to be altered by factors
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such as environmental changes (Kempermann et al. 1997) and modulations of
neurotransmitters (Sun et al. 2009). Because anesthetics also affect these factors, it seems
reasonable to hypothesize that anesthetics may also affect postnatal hippocampal
neurogenesis, and that its alteration may explain cognitive impairment in pediatric and
geriatric patients.
Evidence of adverse effects of general anesthetics on the developing brain
Emerging human and animal data suggest an association between early exposure
to anesthetics and long-term impairment of cognitive function, raising concerns regarding
the safe use of these drugs in young children. Consequently, the prudence of frequent
anesthesia exposure of this population is now being scrutinized.
Current animal data implicate not only N-methyl-d-aspartate (NMDA) receptor
antagonists, but also drugs that potentiate γ-aminobutyric acid (GABA) receptors, as
potentially neurotoxic to the developing brain (Olney et al. 2000; Young et al. 2005).
Drugs that act as (NMDA) receptor antagonists, like ketamine, and those that act in the
(GABA) receptor such as benzodiazepines, induce neuronal injury and neuronal cell
death in the brains of young rodents. Drugs that have effects on one or both of these
receptors include barbiturates, benzodiazepines, inhaled anesthetics such as isoflurane
and nitrous oxide, and intravenous anesthetics such as propofol and ketamine. Not all of
these drugs have been approved for pediatric use, but they are commonly used in this
young population.
In neonatal animal models, isoflurane has been associated with apoptotic
neurodegeneration (Yon et al. 2005; Lu et al. 2006). In rats, a 6-hour exposure to an
anesthetic combination of isoflurane, midazolam, and nitrous oxide, a commonly used
2

combination for long pediatric surgical procedures, has been shown to induce widespread
apoptotic neurodegeneration in newborn animals, and impairment in learning and
memory later in adulthood. Neither nitrous oxide nor midazolam alone produced
neuroapoptosis. In contrast, administration of isoflurane alone caused neuroapoptosis
(Jevtovic-Todorovic et al. 2003). The combination of isoflurane and midazolam produced
a substantial increase in the number of apoptotic cells, and the triple combination of
isoflurane, midazolam, and nitrous oxide produced the greatest increase in the number of
neuroapoptotic cells. Animals treated with the “triple combination” also demonstrated
persistent memory and learning impairments later in life, which correlated with deficits in
hippocampal synaptic function measured electrophysiologically in vitro (JevtovicTodorovic et al. 2003). Preliminary data in neonatal rats from another research group also
suggest that isoflurane, when administered for 4 hours as a single anesthetic drug, alters
fear conditioning and spatial learning in adulthood (Stratmann 2006).
Another widely used general anesthetic used for pediatric surgical procedures is
the intravenous anesthetic, propofol. However, the effects of propofol administration on
neuronal survival and neurocognitive performance have not been formally studied in
young children. A study of the effects of propofol on neuronal structure and
neurocognitive performance in mice suggests that propofol exposure during brain
development increases neurodegeneration, and results in cognitive deficits in adulthood
(Fredriksson et al. 2007). Using in vitro preparations of neuronal cell cultures from
immature chicks and rats, several investigators noted a dose-dependent neuronal
structural change after propofol exposure (Honegger and Matthieu 1996; Spahr-Schopfer
et al. 2000; Vutskits 2005). Supraclinical doses of propofol induced neuronal cell death in
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dissociated cell culture models, but failed to demonstrate neurotoxic effects in
organotypic slice cultures (Spahr-Schopfer et al. 2000). Furthermore, exposure of
dissociated neurons to propofol in clinically relevant concentrations for up to 3 days did
not result in dendritic development changes. In conclusion, no prospective studies have
examined the effects of propofol on neuronal structure and neurocognitive outcome in
young children, whereas several case reports detail short-term neurological abnormalities
without long-term neurocognitive impairment. However, detailed follow-up has not been
conducted in this patient population. A study in neonatal mice points to propofol’s dosedependent

neurodegenerative

properties,

leading

to

behavioral

and

learning

abnormalities, which are exacerbated by the co-administration of ketamine. Animal
studies using in vitro preparations demonstrate only subtle changes, whereas current
evidence fails to reveal injurious effects of propofol on neuronal survival and dendritic
development.
Evidence of adverse effects of general anesthetics on the aging brain
According to the 2004 US census, people over eighty years of aged are the fastest
growing segment of the population, this population grew 30% over the previous decade
(Bureau 2004). Therefore, elders are one of the largest group receiving anesthetics.
Patients over sixty-four years of age have eight-fold more procedures per 10000 people
than patients fifteen years of age or younger, and more than two-fold more than patients
aged 45-64 years old. Moreover, the aging brain becomes more susceptible to
neurodegeneration over time. In other words, the aging brain has less reserve and small
adverse events may have a greater impact on brain function.
In 1998 Moller et al presented the first of a series of multicenter studies on
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cognitive dysfunction after anesthesia. The study included 1,218 patients, aged 60 yr or
older, who underwent major abdominal, non-cardiac thoracic, or orthopedic surgery
during general anesthesia. Patients were tested preoperatively, and at 1 week and 3
months postoperatively. Test results were compared with a total of 321 controls recruited
from the United Kingdom, 11 centers in Europe, and 2 centers in North America. Patients
were classified as experiencing cognitive dysfunction when two Z scores in individual
tests declined by 1.96, or the combined average Z score declined greater than 1.96. At 1
week postoperatively, 25.8% of 1,011 patients experienced a decline in cognitive
function, compared with 3.4% of 176 control subjects. At 3 months postoperatively, 9.9%
of 910 patients experienced a decline relative to preoperative level of function, compared
with 2.8% of controls (Moller et al. 1998b).
A number of subsequent studies have described cognitive impairment within the
first 10 days after surgery and anesthesia (Dodds and Allison 1998). Williams-Russo et al
found a rate of cognitive dysfunction of 5% at 6 months after surgery, although in the
absence of a control population, the significance is hard to determine (Williams-Russo et
al. 1995). A follow-up study that evaluated patients at 1 and 2 yr found that the rate of
cognitive dysfunction decreased to approximately 1%, which was not statistically
significant (Abildstrom et al. 2000). Taken together, it seems that elderly patients
manifest measurable deterioration shortly after surgery and anesthesia (25% at 2–10
days), with gradual resolution such that the incidence declines (10% at 3 months, 5% at 6
months, 1% at 1 yr) to levels nearly indistinguishable from control subjects by
approximately 1 yr. In one study, less than half of the participants who were classified at
having cognitive impairment at 3 months had detectable decline at 1 week. Consequently
5

cognitive impairment at 1 week did not predict cognitive impairment at 3 months,
(Rasmussen and Siersma 2004)
A large clinical study from Duke University now appears to confirm earlier
findings, in the 1998 study (Moller et al. 1998b), showing that significant number of
elderly people experience long term (three or more months) changes in cognitive function
after anesthesia (Monk et al. 2008). One thousand sixty four patients were classified as
young (18-39 years old), middle aged (40-59 years old) or elderly (60 years old or older).
Their cognitive function was assessed with a battery of tests before surgery, at discharge
from the hospital, and 3 months after the discharge. At the discharge form the hospital,
signs of cognitive impairment were present in 30-41% of patients. At the 3-month time
point, young and middle aged patients had recovered, but 12.7% of elderly patients still
showed cognitive impairment. Moreover, patients with cognitive dysfunction were more
likely to die in the year after surgery.
In the laboratory, Culley et al. (2003) found that 2 hours of anesthesia with 1.2%
isoflurane/70% nitrous oxide/30% oxygen produces long-lasting, but reversible
impairment on a previously learned spatial memory task in 18-mo-old-rats. Additionally,
when the same aged animals were exposed to the same concentration of anesthetic for the
same period of time, but the spatial memory task performed two weeks after anesthesia,
the aged rats subject to general anesthesia were less able than control rats to perform well
(Culley et al. 2004a).
The aging brain appears to be more susceptible to anesthetic effects than the adult
brain. This may be due to the several ways in which they are different, including size,
distribution and type of neurotransmitters, metabolic function, capacity for plasticity, and
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inflammation, suggesting that the senescent brain may be more susceptible to anesthetic
changes.
Postnatal neurogenesis in the context of learning and memory
General anesthesia has been implicated as a possible cause of cognitive
impairment. Laboratory data shows that spatial memory is impaired by general
anesthetics in aged rats (Culley et al. 2003). Spatial memory is considered a hippocampal
cognitive domain, even though other areas contribute to spatial learning and memory. An
important determinant of hippocampal function in animals is the degree to which new
neurons are generated from stem cells in the subgranular zone of the dentate gyrus (DG)
of the hippocampus. Neurogenesis in the DG decreases progressively with age (Luo et al.
2006; Shruster et al. 2010), but both a decrease in the levels of the stress hormone
corticosterone (Mirescu et al. 2004) and environmental enrichment (Kempermann et al.
1997) can restore neurogenesis and improve spatial memory function. Thus, cognitive
impairment following anesthetic exposure may be a result of anesthetic-induced
alteration of postnatal neurogenesis.
The process of postnatal neurogenesis
Neurogenesis is the process of generating functionally integrated neurons from
progenitors cells. It was traditionally believed to occur only during the embryonic stage
(Ramon 1913). However, studies of Altman and Das (Altman 1962; Altman and Das
1965) provided the first indication that new neurons are generated in the postnatal
mammalian brain. More recently, it has been recognized that postnatal neurogenesis
replicates the complex process of neurodevelopment in order to generate functional
integrated neurons important for learning and memory. Postnatal neurogenesis in
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mammals is primarily restricted to two brain regions: the subventricular zone (SVZ) of
the lateral ventricles and the subgranular zone (SGZ) of the hippocampal DG. Neural
stem cells proliferate and give rise to new granule cells through the following
developmental stages: proliferation, differentiation, migration, maturation and synaptic
integration (Figure 1) (Ming and Song 2005). These stages can be identified on the basis
of cell morphology, mitotic capability, electrophysiology characteristics, and expression
of developmental regulated markers (Kempermann et al. 2004). Proliferating SVZ cells
form a migrating chain and differentiate into neurons in the olfactory bulb (AlvarezBuylla and Garcia-Verdugo 2002; Lazarini and Lledo 2011). Postnatal hippocampal
progenitor cells divide in the SGZ and develop into neurons in the granular cell layer.
Nascent cells become functionally integrated into the DG and have passive membrane
properties, action potentials and functional synaptic inputs similar to those found in
mature dentate granule cells (Snyder et al. 2005). Newly generated neurons play a
significant role in synaptic plasticity (Ming and Song 2005; Snyder et al. 2005) and the
reduction in the number of these cells impairs learning and memory (Shors et al. 2002).
Neurotransmitters, growth factors, hormones and environmental factors are among the
mediators involved in the regulation of adult hippocampal neurogenesis (Kempermann
2002). GABAergic receptor agonists and NMDA receptor antagonists induce dentate
gyrus progenitor proliferation with increased newborn neurons in the granule cell layer
(Cameron et al. 1995). Enriched environments result in more total granule cell neurons
by increasing the survival rate of the progeny of the dividing progenitor cells
(Kempermann et al. 1997) On the other hand, impaired hippocampal neurogenesis may
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be associated with cognitive decline in aging, major depression and Alzheimer’s disease
(Haughey et al. 2002; Tsuchiya et al. 2003; Raber et al. 2004).
Neural Stem Cells (NSCs) generate significant numbers of progenity in young
rats, with approximately 9000 new cells or 0.1% of the granular cell population being
replaced daily (Cameron and McKay 2001). Approximately 50% of the neuronal
progenity survive, and new granule cells populate the inner third of the granular cell
layer. Postnatal neurogenesis is not a one-step process, as new neurons have to progress
through several distinct developmental steps before they fully integrate and eventually
become indistinguishable from granule cells born during embryonic or early postnatal
development (Laplagne et al. 2006).
Regulation of postnatal neurogenesis
The basic rate of neurogenesis in the DG is thought to be genetically determined
(Cameron and McKay 2001), but it can be regulated by a variety of factors such as
physical activity (van Praag et al. 1999), environmental enrichment (Kempermann et al.
1997), stress (Kempermann et al. 1997; Mirescu et al. 2004), gender, steroids (Tanapat et
al. 1999), inflammation (which reduces the number of newborn cells) (Tanapat et al.
1999; Monje et al. 2003), and aging (Seki and Arai 1995; Kuhn et al. 1996; Tanapat et al.
1999; Luo et al. 2006; Lazarov et al. 2010). There is an exponential decrease of
neurogenesis throughout the life span in rodents, non-human primates and potentially
humans (Galvan and Jin 2007; Lazarov et al. 2010). With advancing age, the proliferative
activity of hippocampal NSCs and neuronal differentiation capacity decline, leading to a
dramatic, approximately 10 fold reduction in net neurogenesis between the age of 2
months and 2 years in a rodent’s life (Kuhn et al. 1996; Kempermann et al. 2002)
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Recently, the amino acid γ-aminobutyric acid (GABA) has emerged as a key
regulator that controls multiple phases of adult neurogenesis. GABA serves as a feedback
regulator of neural production and migration (Bordey, 2007). GABAergic mechanisms
regulate differentiation and the timing of synaptic integration (Ge et al. 2007a).
General anesthetics
General anesthetics are essential to present day medicine, but a detailed
understanding of their mechanism of action is still absent. Nevertheless, progress has
been made in understanding their mechanism at the molecular and cellular levels.
Different molecular targets in various regions of the nervous system are involved in the
multiple components of anesthetic action. General anesthetic agents range from inhaled
anesthetics, such as isoflurane, desflurane, sevoflurane, nitrous oxide and xenon, to
intravenous anesthetics, such as propofol, ketamine, and benzodiazepines. Even though,
these agents are chemically different, their proposed mechanism of action is thought to
affect synaptic transmission by altering GABA and N-methyl-d-aspartate (NMDA)
receptors (Campagna 2003).
Neurotransmitter-gated ion channels, particularly receptors for γ-amino butyric
acid (GABA) and glutamate, are modulated by most anesthetics at both synaptic and
extra synaptic sites. General anesthetics act as either positive or negative allosteric
modulators of ligand-gated ion channels at clinically effective concentrations (Hemmings
et al. 2005). Most inhaled anesthetics enhance GABA receptor function, increasing
channel opening to enhance inhibition at both synaptic and extra synaptic receptor. In
addition they appear to depress excitatory synaptic transmission presynaptically, where
their principal action seems to be a reduction in glutamate release. Most intravenous
10

anesthetics, including propofol, selectively modulate GABA receptor function by
enhancing gating of the receptors by GABA. Because GABA and NMDA mediated
neuronal regulation is essential for postnatal neurogenesis, exposure to general
anesthetics could potentially interfere with the neurogenic process and ultimately result in
cognitive impairment.
Conclusion
In summary, increasing clinical and laboratory data have raised significant
concerns regarding the safety of general anesthetics used on young and old individuals.
General anesthetics have been implicated as a possible cause of cognitive impairment,
because surgery in pediatric and geriatric patients often involves general anesthesia.
General anesthesia has also been shown to impair spatial memory in rats (Culley et al.
2004a; Culley et al. 2004b). One of the factors involved in spatial memory is postnatal
neurogenesis. Alteration of neurogenesis may be a possible reason for the cognitive
impairment experienced in some pediatric and geriatric patients after general anesthesia.
Moreover, neurogenesis is a multistep process, and alteration of one or more of these
stages may result in subtle, but adverse consequences. The effect of anesthesia on the
different stages of neurogenesis is not known. We hypothesize that alteration of
neurogenesis by anesthesia may explain the cognitive impairment observed in some
pediatric and geriatric patients.
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POSTNATAL NEUROGENESIS STAGES

Modified from Ming GL, Song H (2005) Adult neurogenesis in the mammalian central
nervous system. Annu Rev Neurosci 28: 223-250

Figure 1. Postnatal neurogenesis, a developmental process that includes
proliferation and fate speci
ﬁcation of adult neural stem cells along with their
differentiation, maturation, migration and incorporation into the existing neural circuitry
of their progeny in the mature nervous system.
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CHAPTER 1
QUANTITATIVE ASSESSMENT OF NEW CELL PROLIFERATION IN THE
DENTATE GYRUS AND BEHAVIOR AFTER ISOFLURANE OR PROPOFOL
ANESTHESIA IN YOUNG AND AGED RATS

Abstract
Background: There is a growing body of evidence showing that a statistically
significant number of people experience long-term changes in cognition after anesthesia.
We hypothesize that this cognitive impairment may result from an anesthetic-induced
alteration of adult hippocampal cell proliferation.
Methods: To test this hypothesis, we investigated the effects of isoflurane and
propofol on new cell proliferation and cognition of young (4 month-old) and aged (21
month-old) rats that were anesthetized for 3 hours with either 1.5% isoflurane or
35mg/kg/hr propofol. An additional group of young and aged rats exposed to room air or
intralipid, served as controls. All rats were injected intraperitoneally (IP) with 50 mg/Kg
of 5-bromo-2-deoxyuridine (BrdU) immediately after anesthesia. A novel appetitive
olfactory learning test was used to assess learning and memory two days after anesthesia.
One week after anesthesia, rats were euthanized and the brains analyzed for new cell
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proliferation in the dentate gyrus, and migration of newly formed cells in the
subventricular zone to the olfactory bulb.
Results: We found that exposure to either isoflurane (p=0.017) or propofol
(p=0.006) decreased hippocampal cell proliferation in young, but not in aged rats. This
anesthetic-induced decrease was specific to new cell proliferation in the hippocampus, as
new cell proliferation and migration to the olfactory bulb was unaffected. Isoflurane
anesthesia produced cognitive impairment in aged rats (p=0.044), but not in young rats.
Conversely, propofol anesthesia resulted in cognitive impairment in young (p=0.01) but
not in aged rats.
Conclusions: These results indicate that isoflurane and propofol anesthesia affect
postnatal hippocampal cell proliferation and cognition in an age dependent manner.

Keywords: isoflurane, propofol, cognitive impairment, new cell proliferation,
cognition.
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Introduction
Since its introduction to medical practice, anesthetic agents have enabled
surgeries to be performed with ease, ensuring analgesia, unconsciousness and amnesia.
Nonetheless, growing clinical and laboratory data suggest that anesthetic agents have
long lasting consequences that may lead to cognitive impairment (Moller et al. 1998a;
Monk et al. 2008) particularly in elderly and pediatric patients.
Ten to fifteen percent of elderly patients suffer from difficulties with
concentration and attention after anesthesia (Moller et al. 1998b). Furthermore, recent
studies suggest an association between early exposure to general anesthesia and longterm impairment of cognitive function in pediatric patients (Wilder et al. 2009). This
phenomenon has been observed in animal models. Culley and colleagues (2004a, 2004b)
reported enduring deficits in spatial working memory of aged rats after exposure to
isoflurane, nitrous oxide, or isoflurane-nitrous oxide anesthesia (Culley et al. 2004a;
Culley et al. 2004b). Similarly, young rats exposed to isoflurane show persistent memory
and learning deficits (Jevtovic-Todorovic et al. 2003; Culley et al. 2004a; Zhang et al.
2008).
Postnatal generation of neurons occurs throughout life and has been clearly
demonstrated in two brain regions, the subgranular zone (SGZ) of the dentate gyrus (DG)
in the hippocampus and the subventricular zone (SVZ) of the lateral ventricle where new
neurons migrate into the olfactory bulb (OB) (Altman and Das 1965; Eriksson et al.
1998; Gage 2002; Ming and Song 2005; Taupin 2006a; Taupin 2006b). This process is
more pronounced during early postnatal life and decreases with age (Galvan and Jin
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2007; Lazarov et al. 2010), which may make new cell proliferation at these time periods
more susceptible to insults. Postnatal neurogenesis in the DG has been shown to be
involved in learning and memory (Kempermann 2002; Shors et al. 2002; Zhao et al.
2008; Jessberger et al. 2009). However, the effects of anesthetics on neurogenesis are not
well understood, raising concerns regarding the effect of certain anesthetic agents on
cognition.
In this study, we investigated whether isoflurane and/or propofol affected learning
and new cell proliferation in the brain of young and aged rats shortly after administration
of anesthesia. We hypothesized that cognitive impairment following anesthesia may
result from an anesthetic-induced alteration of hippocampal new cell proliferation.
Evaluation of new cell proliferation immediately following anesthesia constitutes the first
step for a more extensive study of the effects of anesthesia on neurogenesis.

Materials and Methods
All experiments were conducted in accordance with the National Institute of
Health Guide and Use of Laboratory Animals, and were approved by the Institutional
Animal Care and Use committee of the University of South Florida, College of Medicine,
Tampa, Fl.
Animals: to evaluate the effects isoflurane and propofol on the developing and
aging brain, rats of two different ages were used for this study: 4-month old (young) and
21-month old (aged) male Fischer-344 rats (Harlan Sprague Dawley, Indianapolis, IN).
All rats were acclimated and handled for two weeks prior to the beginning of the
experimental procedures.
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Isoflurane Anesthesia: one cohort of rats was randomly assigned to four
different groups (n=12 per group): young rats exposed to 1.5% isoflurane delivered in 2
L/min O2 via nose cone for 3 hours, young rats exposed to a mixture of air and 2 L/min
O2 in the cage for 3 hours, aged rats exposed to 1.5% isoflurane delivered in 2 L/min O2
via nose cone for 3 hours, and aged rats exposed to a mixture of air and 2 L/min O2 in the
cage for 3 hours. Isoflurane (Forane, Ohmeda Caribe, NJ, USA) was delivered via a
standard anesthesia vaporizer. Perioperiative parameters such as body temperature,
oxygen saturation and heart rate were measured throughout the anesthesia period. Body
temperature of rats was maintained at 37°C with a thermostatically controlled heating
pad.
Propofol Anesthesia: a separate cohort of rats was randomly assigned to four
different groups breathing air (n=10 per group): young rats that received 35 mg/kg/hr of
propofol or 10% intralipid (control) for 3 hrs, and aged rats that received 35 mg/kg/hr of
propofol or 10% intralipid for 3 hours. Unanesthetized rats were placed in a restrainer
and a tail vein catheter was implanted and attached to a syringe pump (model 11 Plus;
Harvard Apparatus). Propofol (Disoprivan; AstraZeneca) or 10 % intralipid (Fresenius
Kabi; Sweden) that served as control was continuously administered for 3 hours. Body
temperature of rats was maintained at 37°C with a thermostatically controlled heating
pad.
BrdU Injections: to evaluate the effects of isoflurane and propofol on new cell
proliferation in the brain, 5-Bromo-2-deoxyuridine (BrdU; Sigma-Aldrich Munich,
Germany) was injected intraperitoneally at a dose of 50 mg/kg in all groups immediately
following the anesthesia or control procedure and 18 hours after the first injection.
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Cognitive assessment: cognitive function was assessed using a task that requires
the rats to make odor-reward associations using foraging for palatable food, which results
in rapid acquisition with minimal stress and fear (Eichenbaum 1998). Rats performed the
novel odor discrimination task two days after exposure to either isoflurane or propofol
anesthesia. Rats were initially habituated to a 97 cm2 black Plexiglas box, and shaped to
receive treats in the box. Rats were food deprived the night prior to behavioral testing.
Two odors were presented in adjacent corners of the box. A treat was placed next to one
odor while the second odor was not paired to a reward (Fortin et al. 2002). The rat was
placed in the middle of the box facing away from the odors and reward and allowed to
explore the novel odors and find the reward. The position of the odor/reward pair was
randomized between trials. Each rat received ten learning trials (120 seconds cut off).
Each rat received one test trial, which assessed accuracy of memory and time to reach the
reward. An Etho Vision computerized tracking and movement analysis system (Noldus
Information Technology) was used to record and collect behavioral data. Due to technical
difficulties with the tracking system, number of errors and time spent on each corner
during the olfactory task was only recorded for young rats exposed to either propofol or
intralipid. A blinded individual performed the behavioral experiment, and all equipment
used for behavioral testing was wiped with 70% ethanol between animal uses to eliminate
olfactory trails.
Tissue preparation and BrdU immunohistochemistry: one week after
anesthesia, rats were deeply anesthetized with pentobarbital (50 mg/kg, i.p.) and
transcardially perfused with 100 ml saline. Brains were removed, and immersion fixed in
4% paraformaldehyde for 5 days, and then placed in 20% sucrose. Frozen sagittal
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sections (30 μm) through the entire DG were collected serially. Sections were pretreated
with 50% formamide/2X Saline-Sodium Citrate (SSC) at 65°C for 2 hours, rinsed in 2X
(SSC), incubated in 2N HCL for 30 minutes at 37°C, and then washed with borate buffer
(pH 8.5), followed by phosphate buffered saline (PBS). Subsequently, endogenous
peroxidase activity was quenched with 3% H2O2 solution in PBS. Sections were blocked
for 1 hour in 3% normal horse serum and 0.25% Triton X-100 in PBS (PBS-TS).
Sections were incubated overnight with mouse-anti-rat-BrdU (1:100; Roche) in PBS-TS.
The following day, sections were washed in PBS, incubated for one hour in biotinylated
secondary antibody (horse anti-mouse IgG rat adsorbed 1:200; Vector Laboratories,
Burlingame, CA) in PBS-TS, and washed in PBS before incubation for 1 hour in avidinbiotin substrate (ABC kit, Vector Laboratories, Burlingame, CA). Sections were washed
in PBS for 10 minutes and reacted with 3,3´- diaminobenzidine tetrahydrochloride (DAB)
solution (Thermo Scientific, Rockford, IL). Sections were then mounted onto glass slides,
dehydrated, and coverslipped with mounting medium (Cytoseal 60,Stephens Scientific,
Riverdale)(Bachstetter et al. 2010).
Microscopy: unbiased stereological methods were used to estimate the numbers
of BrdU labeled cells (BrdU+) in the subgranular zone of the DG. Twelve equally spaced
sections throughout the medial-lateral extent of the DG were collected. Because BrdU+
cells are a rare event, the number of BrdU+ cells in each DG examined was summed for
individual animals and the sum from each animal was then multiplied by the section
spacing to estimate the total number of BrdU+ cells (Mouton 2002). These data were then
used to calculate group means for estimates of total BrdU+ cells. Labeled cells that were
greater than 1 cell diameter away from the subgranular layer were not included in the
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count (Figure 2). Only cells that had a clearly defined nuclear outline, with speckled or
solid labeling over the nucleus, were considered BrdU positive. BrdU+ cells were
visualized using a bright field microscope by an individual blinded to the treatment of the
animals.
Statistical analysis: statistical analysis was performed using a two-way analysis
of variance (ANOVA) for repeated measurements followed by a Tukey’s post-hoc test.
All results are presented as the mean ± SEM. Statistical comparison of the data was
performed using GraphPad Prism version 5.00 for Mac (GraphPad Software, San Diego
California USA, www.graphpad.com)

Results
Physiological parameters: perioperiative variables were recorded every thirty
minutes during the anesthesia procedure. Body temperature of the rats was maintained at
37°C. Oxygen saturation averaged 85% and 86%, respectively, for aged and young rats
exposed to propofol, and 94% and 95%, respectively, for aged and young rats exposed to
isoflurane. Heart rate averaged 327 and 340 beats per minute, respectively, for aged and
young rats exposed to propofol, and 297 and 328 beats per minute, respectively, for aged
and young rats exposed to isoflurane.
New cell proliferation in the DG of young rats is decreased by isoflurane
anesthesia: figure 3 shows new cell proliferation assessed immediately after isoflurane
anesthesia. A two-way Analysis of Variance ANOVA (F3, 27= 67.39; p= 0.017) revealed
that, when compared to the control group, isoflurane anesthesia significantly decreased
the number of BrdU+ cells in the subgranular zone (SGZ) of the DG of young rats. There
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was not a statistical difference in the number of BrdU+ cells between aged rats exposed
to isoflurane and aged control rats (p= 0.084). As previously reported (Seki and Arai
1995; Garcia et al. 2004; Luo et al. 2006; Lazarov et al. 2010), we found a decrease in
new cell proliferation in aged, as compared to young, rats (p< 0.0001).
New cell proliferation in the DG of young rats is decreased by propofol
anesthesia: new cell proliferation was assessed immediately after propofol anesthesia
(Figure 4). A two-way ANOVA (F3, 30= 51.13; p= 0.006) revealed that, when compared
to the group exposed to intralipid, propofol anesthesia significantly decreased the number
of BrdU+ cells in the DG of young rats. There was not a statistical difference in the
number of BrdU+ cells between aged rats exposed to propofol and aged rats exposed to
intralipid (p= 0.181). We also found a decrease in new cell proliferation in aged, as
compared to young, rats (p< 0.0001) as expected.
The number of BrdU+ cells in the olfactory bulb is not altered by either
isoflurane or propofol anesthesia: to assess whether anesthesia produced an overall
decline in cell proliferation, the number of BrdU+ cells was counted in the granular and
glomerular cell layer of the olfactory bulb (Figure 5 and Figure 6). No significant
difference was found in the number of BrdU+ cells in the glomerular or granule cell
layers in rats exposed to either propofol or isoflurane anesthesia when compared with
controls. However, a decrease in new cell proliferation in aged, as compared to young
rats (p< 0.0001) was found.
Isoflurane causes cognitive impairment in aged rats: cognitive function was
assessed two days after rats were exposed to isoflurane (Figure 7). Data were analyzed
using a two-way ANOVA with repeated measures and revealed that young rats learned
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the task (p<0.0001). Aged rats also acquired the task (p<0.0001), though not as rapidly as
young rats. Aged rats exposed to isoflurane showed a deficit in learning, as compared to
the aged rats that served as controls exposed to room air (F3,

38=

21.11; p= 0.044).

Learning in young rats exposed to isoflurane was not impaired as compared to the young
control group (p= 0.495).
Propofol causes cognitive impairment in young rats: cognitive function was
assessed two days after rats were exposed to propofol (Figure 8). Data were analyzed
using a two-way ANOVA with repeated measures and revealed that young rats learned
the task (p<0.0001). Aged rats also acquired the task (p<0.0001), though not as rapid as
young rats. Young rats exposed to propofol showed a deficit in learning, as compared to
other groups (F3, 40= 17.58; p= 0.01). Learning in the aged group exposed to propofol was
not impaired when compared to the aged control group (p= 0.067) (Figure 8A).
Moreover, young rats exposed to propofol were making significantly more errors than
young controls (F1, 12= 6.49; p= 0.026) (Figure 8B). When examining the amount of time
spent in the correct vs. the incorrect corner (Figure 8C), it was found that young rats
exposed to propofol were spending significantly more time in the incorrect corner as
compared to young controls (F3, 296= 4.71; p= 0.0038).

Discussion
Effect of isoflurane and propofol on new cell proliferation in the brain: our
study reveals three interesting results. First, as previously reported (Seki and Arai 1995;
Garcia et al. 2004; Luo et al. 2006; Lazarov et al. 2010), we found a decrease in new cell
proliferation in aged rats compared to young rats, in both neurogenic regions. With
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increasing age, there is a dramatic decline in subventricular zone and DG cell
proliferation.
Second, three hours of isoflurane or propofol anesthesia affect DG cell
proliferation immediately after anesthesia in young rats, while new cell proliferation in
the DG of aged rats is unaffected, suggesting an age dependent susceptibility. Cell
proliferation in the young DG, although occurring at the higher rate, seems more
susceptible to propofol and isoflurane anesthesia than DG cell proliferation in the aged
brain (Shruster et al. 2010). Similar studies by other groups have shown an alteration of
DG cell proliferation in P60 and P7 rats after 4 hours of isoflurane anesthesia (Stratmann
et al. 2009).
Third, we found that while isoflurane or propofol anesthesia resulted in a decrease
in the number of Brdu+ cells in the DG of young rats, the number of Brdu+ cells in the in
the granular and glomerular cell layer of the olfactory bulb (OB) was unaffected. In this
study, we wanted to examine whether the anesthetic agent effect was confined to the DG
or if there was a generalized effect on progenitor cell proliferation in the brain with
anesthesia. We found that isoflurane and propofol seem to have a specific effect on the
DG. New cell proliferation in the DG may be more susceptible to disruption by
anesthetics than new cell proliferation in the SVZ. For example, a reduction in new cell
proliferation in the SGZ, but not in the SVZ has been reported after low-dose irradiation
of the heads of adult rodents (Tada et al. 2000; Mizumatsu et al. 2003; Snyder et al.
2005).
Few studies have focused on DG cell proliferation with propofol anesthesia.
Studies report no alterations in cell proliferation after 6 hours of propofol via jugular vein
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catheter and 100 mg/kg of BrdU given intraperitoneally (Lasarzik 2006). Similarly, a
study in which young and middle-aged Sprague Dawley rats received one of four
anesthetics (propofol, isoflurane, dexmedetomidine, and ketamine) for 8 hrs and received
200 mg/Kg BrdU during the anesthetic period found no effect of the anesthetics on DG
cell proliferation (Tung et al. 2008). The discrepancies between these studies and ours
may be due to differences in the rat strain (F344 vs. Sprague Dawley), the timing of the
anesthetic (6 hrs vs. 3 or 4 hrs), the dose of BrdU (100, 200 or 50 mg/Kg), or timing of
the BrdU injection (before, during or following anesthesia).
Effect of isoflurane and propofol anesthesia on cognitive function: cognitive
impairment has been observed in aged rats (18-20 month old) following exposure to
anesthesia using the 12-arm radial arm maze. When studying the effect of anesthesia on
old memory retrieval, aged rats were impaired while adult rats improved their
performance (Culley et al. 2003). On the other hand, when animals were tested for new
memory formation 2 weeks after exposure to anesthesia, aged animals were impaired
(Culley et al. 2004a) while adult animals (6 month old) showed no impairment (Crosby et
al. 2005). In our study, aged animals in the control group took less time to find the reward
than aged animals exposed to isoflurane even though both groups learned the task. Aged
animals in the isoflurane group took more time to reach the reward and made more errors
during the task than aged control animals. Therefore, learning was delayed by the
anesthetic. When looking at the effect of isoflurane on cognition on young animals under
the same testing conditions, we found that cognitive function is unaffected by isoflurane
exposure. Our study, supports previous findings of cognitive impairment after isoflurane
anesthesia (Culley et al. 2003; Culley et al. 2004a; Culley et al. 2004b)
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Propofol is widely used among pediatric and geriatric patients. However, there are
few studies on its effect on cognitive function in an animal model. In one study, propofol
anesthesia in aged rats (18 month old) did not affect spatial memory assessed by the 12arm-radial maze (Lee et al. 2008). Similarly, in our study, propofol anesthesia had no
effect on cognition in aged rats using the olfactory association task. However, we found
that, similar to isoflurane, propofol had an age dependent effect, though opposite to that
found with isoflurane. Propofol caused cognitive impairment in young animals.
Conclusion: in summary, we found that isoflurane and propofol anesthesia
produce cognitive impairments as assessed by our olfactory behavioral paradigm that are
age, and agent dependent. The effect on progenitor cell proliferation is age dependent and
selective to the dentate gyrus. Furthermore, propofol in young animals impairs learning
and decreases progenitor cell proliferation. This study is the basis for more detailed
studies on the effect of these two anesthetic agents on the process of neurogenesis.
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Figure 2. Immunohistochemical labeling of proliferating cells within the dentate
gyrus (DG) with bromodeoxyuridine (A) 4 month-old propofol (B) 4 month-old intralipid
(C) 21 month-old propofol (D) 21 month-old intralipid.
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Figure 3. New cell proliferation in the DG of young rats is decreased by
isoflurane anesthesia. Number of BrdU+ cells in the dentate gyrus (DG) of young (4
month-old) and aged (21 month-old) rats, after 3 hours of 1.5% isoflurane anesthesia
(isoflurane) or no isoflurane (control). There is a statistically significant difference between
young control and young isoflurane-exposed rats (*p= 0.0171), but not a statistically
significant difference in the aged groups.
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Figure 4. New cell proliferation in the DG of young rats is decreased by
propofol anesthesia. Number of BrdU+ cells in the dentate gyrus (DG) of young (4 monthold) and aged (21 month-old) rats, after 3 hours of 35 mg/Kg/hr of propofol anesthesia
(propofol) or 35 mg/kg/hr *p= 0.0171.of 10% intralipid (intralipid). There is a statistically
significant difference between young intralipid and young propofol-infused rats (*p=0.0062),
but there is not difference in the aged groups.
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Figure 5. The number of BrdU+ cells in the olfactory bulb is not altered by
isoflurane. Number of BrdU+ cells in the granular and glomerular cell layer of the olfactory
bulb (OB) of young (4 month-old) and aged (21 month-old) rats, after 3 hours of 1.5%
isoflurane anesthesia (isoflurane) or no isoflurane (control). There was not a statistically
significant difference between the controls and the isoflurane-exposed rats.
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Figure 6. The number of BrdU+ cells in the olfactory bulb is not altered by
propofol anesthesia. Number of BrdU+ cells in the granular and glomerular cell layer of
the olfactory bulb (OB) of young (4 month-old) and aged (21 month-old) rats, after 3 hours
of 35 mg/Kg/hr of propofol anesthesia (propofol) or 35 mg/kg/hr of 10% intralipid
(intralipid). There was not a statistically significant difference between the controls and the
isoflurane-exposed rats.
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Figure 7. Isoflurane causes cognitive impairment in aged rats. This graph
shows the average time to find reward during the olfactory learning test of young (4 monthold) and aged (21 month-old) rats 7 days after 3 hours of 1.5% isoflurane anesthesia
(isoflurane) or no isoflurane (control). Animals were tested on the behavioral paradigm two
days following isoflurane anesthesia. Aged rats also acquired the behavioral task (p<0.0001),
though not as rapid as young rats. Learning in aged animals was impaired by isoflurane (*p=
0.0443).
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Figure 8. Propofol causes cognitive impairment in young rats. Rats were tested
on the behavioral paradigm two days following propofol anesthesia. (A) This graph shows
the average time to find reward during the olfactory learning test of young (4 month-old) and
aged (21 month-old) rats 7 days after 3 hours of 35 mg/Kg/hr of propofol anesthesia
(Propofol) or 35 mg/kg/hr of 10% intralipid (intralipid). Aged rats also acquired the
behavioral task (p<0.0001), though not as rapid as young rats. Learning in young rats was
impaired by propofol (*p=0.0099). (B) This graph shows the number of errors made by
young rats exposed to either propofol or intralipid during the olfactory learning test. Young
rats exposed to propofol made significantly more errors than young controls (p=0.026). (C)
Time spent in correct vs. incorrect corner of young rats exposed to either propofol or
intralipid. Young rats exposed to propofol spent significantly more time in the incorrect
corner than young rats exposed to intralipid (*p= 0.0038). In addition, young rats exposed to
propofol spent significantly more time in the incorrect vs. the correct corner (**p=0.0167).
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CHAPTER 2
THE INHALATION ANESTHETIC ISOFLURANE AFFECTS NASCENT CELLS
UNDERGOING MATURATION AND SYNAPTIC INTEGRATION IN THE
DENTATE GYRUS OF AGED, BUT NOT YOUNG RATS

Abstract
Background: Worldwide, volatile anesthetics are used in millions of young and
elderly patients. Nevertheless, recent studies on human and animals suggest that
anesthesia early or late in life may cause cognitive impairment, the mechanism of which
is still unknown. Postnatal hippocampal neurogenesis is involved in learning and memory
(Culley et al. 2004a; Coras et al. 2010), and an anesthetic-induced alteration of postnatal
neurogenesis may, in part, explain the cognitive impairment observed after anesthesia.
This study asserts the effects of isoflurane on neurogenesis. Even though, the majority of
studies focus on the effects of isoflurane on postnatal neurogenesis after the exposure,
this study concentrates on the effects of isoflurane on the undergoing neurogenesis at the
time of exposure.
Methods: 1.5% isoflurane in 2L/min O2 was administered via nose cone for 3
hours to 3-month-old and 20 month-old F344 rats. Three different thymidine analogs
(CldU, IdU, and EdU) were intraperitoneally injected at three different time points (21
days, 8 days, and 4 days, respectively) prior to isoflurane or control exposure in order to
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assess integration, maturation and differentiation of nascent cells in the dentate gyrus
(DG) at the time of isoflurane anesthesia. Moreover, phenotype identification at each
time point was assessed by co-localization of each thymidine analog with the
corresponding histological marker for each stage of neurogenesis. TUNEL assay was also
performed to assess cell death in the DG after isoflurane.
Results: In this study, isoflurane did not affect any stage of postnatal
neurogenesis in young rats. Even though, no differences were detected on hippocampal
progenitor proliferation, nascent cell differentiation, or migration and axon dendrite
targeting of nascent cells in the hippocampus of aged rats, isoflurane significantly
decreased the number of nascent cells that were in the process of integration at the time
of exposure (p=0.022) only in the aged rats. Additionally, it was found that in aged rats;
isoflurane significantly reduced neuronal production (p=0.008), while astrocyte
production was significantly increased (p=0.003). A significant effect of isoflurane on
cell death was not found.
Conclusion: These results suggest an age and stage dependent effect of
isoflurane. Because isoflurane anesthesia appears to be particularly harmful to the aged
brain, especially to nascent cells undergoing maturation and synaptic integration in the
dentate gyrus of the hippocampus.

Keywords: isoflurane, cognitive impairment, postnatal neurogenesis, cognition
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Introduction
Increasing clinical and laboratory findings suggest long-term or even permanent
impairment of cognitive function following the administration of an anesthetic drug
(Moller et al. 1998; Loepke and Soriano 2008). A commonly used agent to induce and
maintain general anesthesia is the inhaled anesthetic isoflurane, which is widely used in
various types of surgery in pediatric and geriatric patients. Isoflurane is thought to
produce its effects by acting as a γ-aminobutyric acid (GABA) agonist and a N-methyl-daspartate (NMDA) receptor antagonist. Recent laboratory data indicate that isoflurane
exposure induces neurodegeneration in newborns (Jevtovic-Todorovic et al. 2003; Li et
al. 2007), and that anesthesia exposure during development is a significant risk factor for
impairment of cognitive function later in life (Wilder et al. 2009). Additionally, Culley et
al. found that in 18-mo-old rats, anesthesia for 2h with 1.2% isoflurane/nitrous
oxide/oxygen produces long lasting, but reversible impairment on a new and on
previously learned spatial memory task (Culley et al. 2003; Culley et al. 2004a). Spatial
memory is considered to be a hippocampal cognitive domain (Snyder et al. 2005). An
important determinant of hippocampal function is postnatal generation of neurons
throughout life in certain areas of the brain, particularly the dentate gyrus (DG) of the
hippocampus, and the subventricular zone (SVZ) of the lateral ventricle (Eriksson et al.
1998; Gage 2002; Coras et al. 2010). Postnatal neurogenesis is more pronounced early in
life and decreases with age (Luo et al. 2006; Galvan and Jin 2007; Lazarov et al. 2010).
Even though prior studies label neurogenic cells after isoflurane exposure (Tung et al.
2008; Stratmann et al. 2010), this study considers it important to label neurogenic cells
prior to isoflurane exposure, in order to study its effects on each stage of postnatal
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neurogenesis. Postnatal neurogenesis is not a one step but a multi step process that
involves the proliferation of progenitors, differentiation and maturation of the nascent
cells, and the incorporation of these cells into the existing circuit. And an alteration of
one or more of these stages may result in cognitive dysfunction.

Material and Methods
Animals: all experiments were conducted in accordance with the National
Institute of Health Guide and Use of Laboratory Animals, and were approved by the
Institutional Animal Care and Use committee of the University of South Florida, College
of Medicine. Male Fisher 344 (F344) rats (Harlan Sprague Dawley, Indianapolis, IN),
were pair-housed in environmentally controlled conditions (12:12h light: dark cycle at
21±1°C) and provided food and water ad lib. Rats of two age groups were used in this
study, young (3 months-old) and aged (20 months-old). Rats were excluded from the
study if they became jaundiced, or had abdominal tumors.
Experimental timeline: three different thymidine analogs (CldU, IdU, and EdU)
were intraperitoneally injected at three different time points (21 days, 8 days, and 4 days,
respectively) prior to the anesthetic or control exposure in order to assessed integration,
maturation and differentiation of nascent cells in the dentate gyrus (DG) at the time of
isoflurane anesthesia. Moreover, phenotype identification at each time point was assessed
by co-localization of each thymidine analog with the corresponding histological marker
for each neurogenic stage. Quantification of co-localization of CldU and the mature
neuronal marker NeuN or the astrocytic marker S100β assessed nascent cells undergoing
synaptic integration at the time of isoflurane anesthesia. Quantification of co-expression
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of IdU and the immature neuronal marker DCX or the astrocytic marker S100β assessed
nascent cells undergoing migration and axon/dendrite targeting. Furthermore, by
determining co-localization of EdU with the immature neuronal marker DCX or the
astrocytic marker S100β nascent cells undergoing differentiation were assessed. Lastly,
nascent cells proliferation was assessed using the endogenous marker Ki67. Labeling of
each neurogenic stage was performed in the same animal (Figure 9).
Preparation and administration of thymidine analogs: solutions of 5-Chloro2’-deoxyuridine (CldU) and 5-Iodo-2’-Deoxyuridine (IdU) were prepared at equimolar
concentrations. CldU (Sigma #C6891) was prepared at 17 mg/ml and IdU (MP#100357)
at 23 mg/ml. Injections at 2.5 ml/Kg resulted in an equimolar final effective delivery of
42.5 mg/Kg CldU or 57.5 mg/Kg IdU, as previously described (Vega and Peterson 2005).
Both halogenated thymidine analog solutions were prepared in sterile saline and
administered by intraperitoneal (IP) injection to ensure precise delivery to facilitate
quantitative comparisons. Because cell division is a rare event in the subgranular zone of
elderly rats and because many of these newborn cells do not survive, we were concerned
that a short thymidine analog labeling protocol would not yield a new cell number
sufficient for a meaningful analysis. Therefore, three times the thymidine analog
corresponding to a specific time point was administered; three IP injections at 4-hour
intervals in one day were given. As shown in Figure 9, animals in all groups were
injected with CldU, 21 days before control or isoflurane exposure; and IdU, 8 days before
control or isoflurane exposure.
A solution of 5-ethynyl-2’-deoxyuridine (EdU) was prepared at a concentration of
60 mg/ml in sterile saline. IP injections of EdU (cat #. E10187, Invitrogen, Carlsbad, CA)
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resulted in a final effective delivery of 160 mg/Kg., Animals in all groups were injected
only once with EdU, 4 days before isoflurane anesthesia (Figure 9).
Isoflurane anesthesia: after a two week acclimation period to the vivarium under
standard conditions, rats were randomly assigned to four different groups (n=8 per
group): young rats exposed to 1.5% isoflurane delivered in 2 L/min O2 via nose cone for
3 hours, young rats exposed to a mixture of air and 2 L/min O2 in the cage for 3 hours,
aged rats exposed to 1.5% isoflurane delivered in 2 L/min O2 via nose cone for 3 hours,
and aged rats exposed to a mixture of air and 2 L/min O2 in the cage for 3 hours.
Isoflurane (Forane, Ohmeda Caribe, NJ, USA) was delivered via a standard anesthesia
vaporizer. Body temperature of rats was maintained at 37°C throughout the anesthesia
period with a thermostatically controlled heating pad.
Measurement of physiological parameters during isoflurane anesthesia:
rectal temperature was monitored throughout the exposure and recorded every 30 minutes
using a thermalet-monitoring thermometer (Physitemp instrument Inc, Clifton, NJ, USA).
Moreover, hemoglobin oxygen saturation (SpO2) and heart rate (HR) were recorded
every 30 minutes using the SurgiVet multi-parameter monitor (Smiths medical, Dublin,
OH, USA). Diastolic, systolic and mean arterial pressures were measured every 30
minutes throughout the anesthesia period by tail cuff using the CODA non- invasive
blood pressure system for rats (CODA2, Kent Scientific Corporation).
Tissue collection and processing: twenty-four hours after control or isoflurane
exposure, rats were deeply anesthetized with pentobarbital (50 mg/ Kg, i.p) and
transcardially perfused with 100 ml saline followed by ice-cold 4% paraformaldehyde in
0.1M PBS. Brains were removed, postfixed in the same fixative solution at 4°C
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overnight, transferred to 20% sucrose in PBS until equilibrated, and then frozen in
Tissue-Tek OCT before cryostat sectioning. Sagittal cryosections (30 µm thick) through
the entire DG were collected serially, transferred to a cryoprotectant solution, and stored
at -20°C until used. These sections were used to assess proliferation and phenotypic
determination of nascent cells in the DG. All standard staining procedures were
conducted on free-floating sections using every twelfth section through the entire
hippocampus beginning with a random start and including sections before and after the
hippocampus to ensure that the entire structure was sampled.
CldU and IdU immunohistochemistry: sections were washed three times for 10
min in PBS before being treated with 0.2N HCL for 10 min at 37°C for DNA denature to
facilitate antibody access, sections were then washed with borate buffer (pH 8.5),
followed by three washes of PBS. Sections were then incubated in 5% normal goat serum
and 0.25% Triton X-100 in PBS (PBS-TS) for 60 min, and stained at 4°C. Detection of
halogenated thymidine analogs was accomplished using rat anti-BrdU (Accurate cat#
OBT-0030; clone BU1/75) at 1:250 for CldU and mouse anti-BrdU (Becton Dickinson
cat# 347580; clone B44) at 1:500 for IdU. All secondary antibodies were used at 1:300
and were conjugated to the fluorophore Alexa 594 or Alexa 488.
EdU labeling protocol: EdU labeling was performed using Click-iTTM EdU
imaging kit cat # C10339 (Invitrogen, Carlsbad, CA) according to the manufacturer’s
protocol. This protocol is normally intended for use in cell culture, but was adapted for
histological staining of brain tissue. Sagittal cryosections (30 µm thick) were washed
three times for 10 min in PBS. After washing twice with 3% bovine serum albumin
(BSA) in PBS, sections were permeablized with 0.5% Triton X-100 in PBS for 20 min.
50

Sections were then washed twice with 3% BSA in PBS and incubated with the ClickiTTM reaction cocktail (CuSO4, Alexa Fluor 594 Azide, and manufacture’s reaction
buffer additive) for 30 min while protected from light. Sections were washed one more
time with 3% BSA in PBS, mounted onto glass slides, and coverslipped with Vectashield
mounting medium for fluorescence (cat# H-1000 Vector Laboratories, Burlingame, CA,
USA).
Double immunohistochemistry for lineage markers: the phenotypes of CldU,
IdU and EdU labeled cells were determined using double immunofluorescent staining.
Antibodies against doublecortin (DCX), neuronal nuclei (NeuN) and S100β were used to
detect immature neurons, mature neurons and astrocytes, respectively. DNA
denaturation, followed by incubation of the primary antibodies for CldU and IdU was
performed as described above. A rabbit polyclonal goat antibody raised against human
DCX (1:200 cat# 4604 Cell Signaling technology, Inc. Danvers, MA, USA) was used in
an antibody cocktail with the IdU antibody to assess immature neurons. A mouse
monoclonal antibody against neuronal nuclei, NeuN (MAB377 Millipore, Billerica, MA,
USA) was used at a concentration of 1:500 in an antibody cocktail with the CldU
antibody to assess mature neurons. A rabbit monoclonal goat antibody raised against
S100β (ab52642 abcam, Cambridge, MA, USA) was used at a concentration of 1:3000 in
an antibody cocktail with CldU or IdU to assess astrocytes.
For double labeling of EdU/DCX and EdU/S100β EdU staining was performed
first, followed by incubation with DCX or S100β, respectively.
Ki67 immunohistochemistry: Ki67 is expressed in cells G1 through M phase of
the cell cycle (Scholzen and Gerdes 2000). For detection of Ki67, sections were
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pretreated with 1X Saline-Sodium Citrate (SSC) at 80°C for 40 minutes. Subsequently,
endogenous peroxidase activity was quenched with 0.6% H2O2 solution in PBS for 20
min. Sections were blocked for 1 hour in 2% normal goat serum and 0.25% Triton X-100
in PBS (PBS-TS). Sections were incubated overnight at 4°C with a rabbit polyclonal
antibody against human Ki67 (NCL-Ki67p; Novocastra Laboratories/Vision BioSystems,
Newcastle upon Tyne, UK) at a dilution of 1:2000 in PBS-TS. The following day,
sections were washed in PBS, incubated for one hour in biotinylated secondary antibody
(goat anti-rabbit IgG rat adsorbed 1:1000; BA-1000 Vector Laboratories, Burlingame,
CA) in PBS-TS, and washed in PBS before incubation for 1 hour in avidin-biotin
substrate (ABC kit cat no. PK-6100, Vector Laboratories, Burlingame, CA). Sections
were washed in PBS for 10 minutes and reacted with 3,3´- diaminobenzidine
tetrahydrochloride (DAB) solution (cat no.1856090, Thermo Scientific, Rockford, IL).
Sections were then mounted onto glass slides, dehydrated, and coverslipped with
mounting medium (Cytoseal 60,Stephens Scientific, Riverdale).
Tunel assay protocol: in order to determine if isoflurane had an effect on cell
death, the in situ cell death detection kit, Fluorescein (cat no. 11684795910, Roche,
Mannheim, Germany) was used according to the manufacturer's instructions. Sections
were incubated with 3% bovine serum albumin in 0.1 mol/L Tris-HCL (pH 7.5) for 30
mins followed by 50 µL of TUNEL reaction mixture on each sample for 60 mins at 37°C.
After washing, slides were incubated with 0.3% H2O2 in methanol for 10 mins, followed
by 3% bovine serum albumin in 0.1 mol/L Tris-HCL (pH 7.5) for 30 mins at room
temperature. Incubation with peroxidase-conjugated anti-fluorescein (diluted 1:5) at 37°C
for 30 mins was performed.
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Microscopy and cell counting: unbiased stereological methods were used to
estimate the numbers of positive labeled cells (+ labeled cells) in the subgranular zone of
the DG. Twelve equally spaced sections throughout the medial-lateral extent of the DG
were collected. Because + labeled cells are a rare event, the number of + labeled cells in
each DG examined was summed for individual animals and the sum from each animal
was then multiplied by the section spacing to estimate the total number of +labeled cells
(Mouton 2002). These data were used to calculate group means for estimates of total
+labeled cells. +Labeled cells that were greater than 1 cell diameter away from the
subgranular layer were not included in the count
Sections were imaged on an Olympus FV1000 laser scanning microscope with
four laser sources: 405 Diode, multi-line Argon (for Alexa 488), green HeNe (for Alexa
594), and red HeNe was used for all immunofluorescence photomicrographs. When
quantification of percentage of positive cells was determined, Z stacks were created at 0.5
µm intervals throughout the 30 µm of the sections with a guard region of 2µm excluded
form top and bottom of the Z stack. The Z stacks were rotated in all planes to verify
double labeling. Images of positive staining were adjusted to make optimal use of the
dynamic range of detection.
Statistical analyses: data are presented as mean ± SEM. Analysis of variance
(ANOVA) with Tukeys post hoc or a t-test was used to compare the differences from the
control group. P-values less than 0.05 were considered statistically significant, the
significance testing was one-tailed and GraphPad Prism version 5.00 for Mac (GraphPad
Software, San Diego California USA, www.graphpad.com) was used to analyze the data.
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Results
Physiological parameters during isoflurane anesthesia: rectal temperature was
recorded every 30 minutes during the isoflurane exposure in young (n=8) and aged (n=8)
rats (Figure 10A). The body temperature was between 36 and 37°C during the first hour,
and then it increased almost 1°C and remained stable for the rest of the isoflurane
exposure, with an average of 37±0.23 and 37±0.13 for young and aged rats, respectively.
Mean arterial blood pressure throughout the isoflurane exposure averaged 89.45± 2.74
and 84.8±3.50 for young and aged rats respectively (Figure 10B). Heart rate and
hemoglobin oxygen saturation also remained stable during the 3 hours exposure (Figure
10C). An age difference in most of the measured parameters was detected.
Postnatal proliferation in the Dentate Gyrus, as assessed by the Ki67 marker,
is unaffected by isoflurane anesthesia: the effects of isoflurane exposure (1.5% for 3
hours) on neuronal cell proliferation in the SGZ in young (3 month old) and aged (20
month-old) F344 rats was determined by analyzing Ki-67 labeling, 24 hours after
exposure. Figure 11A shows that Ki67 positive cells in both young and aged rats were
primarily located on the border of the granule cell layer. Isoflurane does not appear to
have an effect on newborn cells generated during the 24 hours after exposure (Figure
11B). The results were subjected to a 2 (age: young, aged) X 2 (treatment: control,
isoflurane) factorial ANOVA. There was a significant effect of age (F (3, 7) = 8.57, p
<0.001), but no significant effect of treatment (F (3, 7) = 0.51, p = 0.818). Isoflurane
exposure did not result in a statistically significant effect in the young (p= 0.248) nor in
the aged rats (p=0.212).
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Isoflurane does not affect nascent cells undergoing differentiation in the DG
of the hippocampus at the time of exposure: we quantified the number of newborn
cells undergoing differentiation at the time of the isoflurane exposure by estimating the
number of EdU positive cells. And determined the phenotype of these newly born cells
using double labeling of EdU and the immature neuronal marker DCX (Figure 12C) and
EdU and the astrocytic marker S100β (Figure 2.4A-B). The results were subject to a 2
(age: young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was a
significant effect of age (F (2,11)= 16.61, p<0.0001), but no significant effect of
treatment (F (2,11)= 6.61, p= 0.06). We found that there was no difference in the number
of EdU+ cells and no difference in the proportion of EdU labeled cells starting to express
neuronal or glial phenotype at the time of isoflurane exposure in young or aged rats
(Figure 12A-B). Our analysis revealed that 57% of the EdU labeled cells in the young
control rats expressed DCX, indicating neuronal differentiation, while only 4.2% of the
EdU labeled cells express S100β, indicating that they have differentiated into mature
astrocytes. When the percentage of each phenotype was summed, it revealed a number
less than 100%, indicating that either some of these cells were already going through
maturation and were expressing the mature neuronal marker NeuN (not quantified at this
time point) or they were still undefined. From a detailed study by Palmer et al. (Palmer et
al. 2000) it is known that at early time points proliferating endothelial cells account for a
large percentage (more than 35% in the rat model of that study) of the dividing cells.
Isoflurane does not affect nascent cells undergoing migration in the DG of
the hippocampus at the time of exposure: we quantified the number of newborn cells
undergoing maturation at the time of the isoflurane exposure by estimating the number of
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IdU positive cells. And determined the phenotype of these newly born cells using double
labeling of IdU and the immature neuronal marker DCX (Figure 13C) and IdU and the
astrocytic marker S100β (Figure 2.5A-B). The results were subject to a 2 (age: young,
aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was a significant
effect of age (F (7,11)= 70.18, p<0.0001), but no significant effect of treatment (F (7,11)=
1.87, p=0.086). We found that there was no difference in the number of IdU+ cells and no

difference in the proportion of IdU labeled cells maturating into neurons or astrocytes at
the time of isoflurane exposure in young or aged rats (Figure 13A-B). Our analysis
revealed that 70% of the IdU labeled cells in the young control rats expressed DCX,
indicating neuronal maturation, while only 15% of the IdU labeled cells express S100β,
indicating that they have differentiated into mature astrocytes. When the percentage of
each phenotype was summed, it revealed a number less than 100%, indicating that either
some of these cells were already going through maturation and were expressing the
mature neuronal marker NeuN (not quantified at this time point).
Isoflurane affects nascent cells undergoing maturation and integration in the
DG of aged, but not young rats: we estimated the number of newborn cells undergoing
synaptic integration at the time of isoflurane exposure by estimating the number of CldU
positive cells, and determined the phenotype of these newly born cells (Figure 14A-B)
using double labeling of: CldU and the mature neuronal marker NeuN (Figure 14C), and
CldU and the astrocytic marker S100β (Figure 2.6D). There was a significant effect of
age (F (7,11)= 16.48, p<0.0001), and a significant effect of treatment (F (7,11)= 1.52,
p=0.04). Isoflurane significantly decreased the number of CldU+ cells (*p=0.02), and the
number of CldU+/NeuN+ cells

(**p=0.008), but increased the number of
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CldU+/S100β+ cells (***p=0.033). We found that isoflurane decreased the number of
CldU labeled cells, neurogenesis, and astrocyte formation in the DG of aged, but not
young rats The number of CldU-labeled cells in aged rats was 36% lower in isoflurane
exposed rats (F (5,32)=5.74 p= 0.022), but unaffected in young rats (Figure 14C-D).
Isoflurane exposure reduced neuronal production, as judged by CldU+/NeuN+ colocalization, significantly in aged rats (*p= 0.008). Conversely, the number of newborn
astrocytes increased significantly in aged rats (***p=0.033) after isoflurane exposure.
Cell death in the Dentate Gyrus after isoflurane exposure: cell death positive
label in the DG was assessed by the DNA strand breaks (TUNEL Assay) in young and
aged rats 24 hours after isoflurane exposure (Figure 15). The results were subject to a 2
(age: young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was not
a significant effect of age (F (2,3)= 3.90, p=0.07), and no significant effect of treatment (F
(2,3)= 0.47, p=0.64). Isoflurane exposure did not result in a statistically significant effect
in the young (p=0.06) nor in the aged rats (p=0.27). The number of cells positive for
TUNEL was not different between isoflurane exposed or control rats, neither in the
young nor in the aged groups (Figure 15). This indicates that isoflurane exposure has no
effect on cell death in the DG.

Discussion
The rate of neurogenesis found in this study is consistent with previous reports of
reduced neurogenesis in aged compared with young animals (Luo et al. 2006; Shruster et
al. 2010). The initial hypothesis of this study was that isoflurane-induced alteration of
one or more stages of postnatal neurogenesis could in part explain the cognitive
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dysfunction experienced in some patients after anesthesia. This hypothesis was based on
recent laboratory data showing that isoflurane exposure early in life results in subsequent
behavioral impairment (Jevtovic-Todorovic et al. 2003; Lu et al. 2006; Li et al. 2007;
Loepke and Soriano 2008), and that isoflurane exposure late in life also produces
enduring cognitive impairment (Culley et al. 2003; Culley et al. 2004a; Culley et al.
2004b). The main findings of this study are that isoflurane causes an alteration in nascent
cells undergoing maturation and synaptic integration in the dentate gyrus (DG) of aged,
but not young rats. Therefore, the effects of isoflurane on postnatal neurogenesis are
stage and age dependent.
Isoflurane has an age dependent effect on postnatal neurogenesis: on this
study, isoflurane was found to be harmful to nascent cells exclusively in the DG of aged
rats. This finding may be attributed to the fact that in general the aged brain appears to be
particularly vulnerable to insults that would go unnoticed at a different age, and to the
fact that with age postnatal neurogenesis exhibits a decline. The aged brain is undergoing
the

involuntary

changes

of

senesce,

and

becoming

more

susceptible

to

neurodegeneration, with Alzheimer’s disease affecting nearly 50% of elders of 80 years
(Xie et al. 2006) (Xie et al. 2007). Moreover, it has being shown that in the aged brain,
NMDA receptor antagonists, such as nitrous oxide and ketamine, produce mitochondria
swelling in cerebrocortical neurons of adult and aged rats, with the aged brain being more
sensitive than the adult brain (Jevtovic-Todorovic and Carter 2005). In addition,
isoflurane has been implicated in Alzheimer’s disease (Xie et al. 2006; Xie et al. 2008;
Zhang et al. 2008). In fact, a number of studies have demonstrated enduring cognitive
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dysfunction in aged, but not young rats anesthetized previously with isoflurane (Culley et
al. 2004a; Culley et al. 2004b).
Postnatal neurogenesis exhibits an age-related decline (Seki and Arai 1995; Luo
et al. 2006; Galvan and Jin 2007; Shruster et al. 2010), which has been associated with
decline in hippocampal-dependent spatial memory (Snyder et al. 2005; Zhao et al. 2008a;
Zhao et al. 2008b; Coras et al. 2010). Despite an age-related reduction in the formation of
nascent hippocampal neurons, the neurons that are added appear functionally equivalent
to those in young brain (Toni et al. 2008). Another study suggest that the number of
neural stem cells does not decline with age, but that these cells rather have a decrease in
the proliferating rate (Lugert et al. 2010) that could be due to a decreased volume of the
vascular niche (Hattiangady and Shetty 2008). Besides the presence or absence of neural
stem cells, the decline of neurogenesis in the aged brain might be due to a loss of
extrinsic signals, a reduced responsiveness of the aging neural stem cells to normal
signaling, or both. Since postnatal neurogenesis requires a specific environment, niche,
that provides the signals needed to maintain and control the developmental stages of
nascent cells (Ming and Song 2005). The neurogenic niche and the nascent cells form a
functional unit that is regulated by signaling of neurotransmitters, neurotrophic factors,
and grow factors (Palmer et al. 2000). Therefore, an age-related alteration in any of these
signaling may account for the particularly susceptibility to isoflurane in the aged rat
brain.
Isoflurane specifically affects nascent cells undergoing maturation and
synaptic integration in the DG of aged rats: to the best of our knowledge, this is the
first study examining the effects of isoflurane anesthesia on each one of the stages of
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postnatal neurogenesis at the time of exposure. By using this experimental model, we
were able to conclude that isoflurane specifically affects nascent cells undergoing the last
neurogenic stage, maturation and synaptic integration. Even though on this current study,
cognitive function was not assessed it may be suggested that disappearance of these cells
has an immediate effect on cognitive function. Culley et al have consistently found
cognitive dysfunction in aged rats up to three weeks after exposure to nitrous oxide,
isoflurane or both (Culley et al. 2004a). However, they were not able to demonstrate
cognitive dysfunction eight weeks after anesthetic exposure. Furthermore, Stratmann et al
using a similar paradigm did not find cognitive dysfunction sixteen weeks after the
anesthetic exposure (Stratmann et al. 2010).
A possible explanation is that consistently with human data showing resolution of
cognitive dysfunction over time. In the majority of patients diagnose one week after
surgery, there is no evidence of cognitive dysfunction three months after surgery and the
majority of patient diagnose at three month after do not suffer from cognitive dysfunction
one or two years after. This is consistent with our findings, isoflurane decreased of
nascent cells undergoing maturation and synaptic integration so disappearance of these
cells has an immediate effect on cognitive function as seen on the clinical setting.
In addition, postnatal neurogenesis after the exposure may not be affected and the
normal cycle of proliferation may be restored so that cognitive function is restored.
Taking together, these findings indicate that depending on the age of the
individual, isoflurane can be either harmful or harmless. Future studies, correlating
immunohistochemistry and behavioral assessment may clarify how isoflurane anesthesia
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may result in cognitive dysfunction in some patients and from that a way of preventing
may be implemented.
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Figure 9. Experimental design. Rats in all groups were injected 21, 8, and 4
days before isoflurane exposure, with CldU, IdU and EdU respectively. In order to study
the effects of isoflurane on integration, maturation and differentiation of neuronal cell
proliferation in the DG of young and aged rats
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Figure 10. Physiological Parameters During Isoflurane Exposure (A) Rectal
temperature was recorded 30 mins after isoflurane induction in young (n=8) and aged
(n=8) rats. Temperature was between 36 and 37°C during the first hour, and then it
increased almost 1°C, and remained stable for the rest of the isoflurane exposure. (B)
Systolic, diastolic and mean arterial blood pressures (mmHg) were also recorded every
30 mins after isoflurane induction in young and aged rats. The blood pressure was stable
during isoflurane inhalation. Blood pressure in the aged rats was slightly less as
compared to the young rats. (C) Hemoglobin oxygen saturation and heart rate were also
recorded every 30 minutes after isoflurane induction in young and aged rats, and were
within normal limits. Data are shown as mean ± SEM.
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Figure 11. Neural Progenitor Cell Proliferation is Unaffected by Isoflurane
Anesthesia (A) Shows the estimated number of Ki67 positive cells in the DG 24 hours
after isoflurane anesthesia in young and aged rats. The results were subjected to a 2 (age:
young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was a
significant effect of age (F (3, 7) = 8.57, p <0.001), but no significant effect of treatment
(F (3, 7) = 0.51, p = 0.818). Isoflurane exposure did not result in a statistically significant
effect in the young (p= 0.248) nor in the aged rats (p=0.212). (B) Immunohistochemical
staining for Ki67 positive cells (20X, upper image) and (40X, lower image) in DG 24
hours after isoflurane exposure in young and aged rats.
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Figure 12. The
Number and Fate of 4
days-old Newborn
Cells in the DG are
Unaffected by
Isoflurane Exposure
(A and B)
(A) Quantification of
EdU+ cells (right
column), EdU+/DCX+
cells (middle column),
and EdU+/S100β+ cells
(left column) in the DG
of young rats after
isoflurane exposure.
(B) Quantification of
EdU+ cells (right
column), EdU+/DCX+
cells (middle column),
and EdU+/S100β+ cells
(left column) in the DG
of aged rats after
isoflurane exposure.
The results were
subject to a 2 (age:
young, aged) X 2
(treatment: control,
isoflurane) factorial
ANOVA. There was a
significant effect of age
(F (2,11)= 16.61,
p<0.0001), but no
significant effect of
treatment (F (2,11)=
6.61, p=0.06) (C)
+
Confocal plane of the same cell, showing co-localization of EdU (red), DCX+ (green)
and EdU+/DCX+ (orange) indicating differentiation into neuronal phenotype. Newly
formed double-labeled cells were visualized using concofal microscopy in an orthogonal
projection composed of 25 optical z-planes (0.5mm thick).
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Figure 13. Cells
undergoing
maturation at 8 days
after birth, are
unaffected by
isoflurane exposure in
young and aged rats.
(A and B)
(A) Quantification of
IdU+ cells (right
column), IdU+/DCX+
cells (middle column),
and IdU+/S100β+ cells
(left column) in the DG
of young rats after
isoflurane exposure.
(B) Quantification of
IdU+ cells (right
column), IdU+/DCX+
cells (middle column),
and IdU+/S100β+ cells
(left column) in the DG
of aged rats after
isoflurane exposure.
The results were
subject to a 2 (age:
young, aged) X 2
(treatment: control,
isoflurane) factorial
ANOVA. There was a
significant effect of age
(F (7,11)= 70.18,
p<0.0001), but no
significant effect of
treatment (F (7,11)= 1.87, p=0.086) (C) Confocal plane of the same cells, showing colocalization of IdU+ (red), DCX+ (green) and IdU+/DCX+ (orange) indicating neuronal
phenotype. Cells undergoing maturation at 8 days were visualized using concofal
microscopy in an orthogonal projection composed of 25 optical z-planes (0.5mm thick).
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Figure 14. Isoflurane exposure affected cells that underwent maturation and started
to integrate in the DG of aged, but not young rats. (A and B) Quantification of CldU+ cells
(right column), CldU+/NeuN+ cells (middle column), and CldU+/S100β+ cells (left column) in
the DG of young (A) and aged (B) rats after isoflurane. The results were subject to a 2 (age:

young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was a
significant effect of age (F (7,11)= 16.48, p<0.0001), and a significant effect of treatment
(F (7,11)= 1.52, p=0.04). Isoflurane significantly decreased the number of CldU+ cells
(*p=0.02), and the number of CldU+/NeuN+ cells (**p=0.008), but increased the
number of CldU+/S100β+ cells (***p=0.033). (C) Confocal plane of the same cell, showing
co-localization of CldU+ (green), NeuN+ (red) and CldU+/NeuN+ (orange) indicating neuronal
phenotype. (D) Single Confocal plane of the same cell, showing co-localization of CldU (red),
S100β+ (green) and CldU+/S100β+ (orange) indicating astrocytic phenotype. Newly formed
double-labeled cells undergoing maturation were visualized using concofal microscopy in an
orthogonal projection composed of 25 optical z-planes (0.5mm thick).
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Figure 15. Cell death in the DG after isoflurane exposure. Quantification of
the TUNEL+ labeling in the DG of young and aged rats, 24 hours after isoflurane
exposure. Isoflurane exposure has no effect on cell death in the DG. The results were
subject to a 2 (age: young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA.
There was not a significant effect of age (F (2,3)= 3.90, p=0.07), and no significant
effect of treatment (F (2,3)= 0.47, p=0.64). Isoflurane exposure did not result in a
statistically significant effect in the young (p=0.06) nor in the aged rats (p=0.27).

72

CHAPTER 3
PROPOFOL ANESTHESIA AFFECTS NASCENT CELLS UNDERGOING
DIFFERENTIATION, AXON/DENDRITE TARGETING AND MIGRATION IN
THE DENTATE GYRUS OF YOUNG BUT NOT AGED RATS

Abstract
Background: Propofol is a widely used agent for anesthetic induction and longterm sedation, due to its favorable profile that ensures a rapid onset of action and a rapid
recovery. However, recent clinical and laboratory studies suggest an association between
commonly used general anesthetics and the impairment of cognitive function. In vitro
studies suggest that propofol may be toxic to developing neurons (Honegger and
Matthieu 1996; Vutskits 2005; Al-Jahdari et al. 2006). Therefore, we hypothesize; that
anesthetic-induced alteration of one or more stages of postnatal neurogenesis may explain
the impairment of cognitive function experienced by some patients.
Methods: 35 mg/kg/hr of propofol or 10% intralipid (control) were continuously
infused via tail-vein catheter for 3 hours to 3 month-old and 20 month-old F344 rats.
Three different thymidine analogs (CldU, IdU, and EdU) were intraperitoneally injected
at three different time points (21 days, 8 days, and 4 days) prior to the anesthetic or
intralipid infusion in order to assessed integration, maturation and differentiation of
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nascent cells in the dentate gyrus (DG) at the time of propofol anesthesia. Moreover,
phenotype identification at each time point was assessed by co-localization of each
thymidine analog with the corresponding histological marker for each stage of
neurogenesis. TUNEL assay was also performed to assess cell death in the DG after
propofol.
Results: no differences were found in hippocampal progenitor proliferation, or
neuronal synaptic integration. Nevertheless, propofol infusion significantly decreased the
number of nascent cells that were in the process of differentiation, migration (p=0.034)
and axon/dendrite targeting (p=0.034) only in young, but not in aged rats. In addition, we
found that in these young rats, propofol significantly reduced neuronal differentiation, as
judged by EdU+/ DCX+ co-localization (p=0.023). Propofol also significantly reduced
the number of cells undergoing migration and axon/dendrite targeting, as assessed by
IdU+/ DCX+ co-localization (p=0.047). Conversely, astrocyte production was
significantly increased (p<0.0001). A significant increased on cell death after propofol
infusion was not found.
Conclusions: These results suggest that propofol has an age and stage dependent
effect. Because, propofol anesthesia appears to be particularly harmful to the young
brain, especially to nascent cells undergoing differentiation, migration and axon/dendrite
targeting.

Keywords: propofol, cognitive impairment, postnatal neurogenesis
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Introduction
Due to the amount of unavoidable surgeries that pediatric and geriatric patients
undergo daily, and to recently found evidence that suggest a relationship between
anesthetic exposure and the development of cognitive dysfunction early and late in life. It
is imperative to study the mechanisms by which this occurs.
Even though, clinically propofol has recently been related to cognitive
dysfunction in pediatric patients (Mellon et al. 2007), in the laboratory setting not much
attention has been given. Propofol is an intravenous anesthetic characterized by a rapid
onset, clear emergence, and lack of cumulative effects observed in the clinical use, which
makes it widely used for induction and maintenance of anesthesia. Despite its remarkable
safety profile, there is emerging interest concerning side effects of propofol particularity
in pediatric patients. Propofol has been involved in neurological sequelae in infants
(Meyer et al. 2010) and experimental in vitro studies suggest that propofol may be toxic
to developing neurons (Honegger and Matthieu 1996; Vutskits 2005). In vivo studies are
needed in order to properly confirm the in vitro findings allowing us to better understand
the clinical situation.
Because cognitive function is in part dependent on the generation of neurons
throughout life, a process known as postnatal neurogenesis, which is a multistep process
including proliferation, differentiation, and maturation of the nascent cells. An alteration
of one or more stages of postnatal neurogenesis may results in impairment of cognitive
function (Kempermann 2002; Dupret et al. 2008; Coras et al. 2010). Thus, it is reasonable
to assume that an anesthetic-induce alteration of postnatal neurogenesis may explain the
cognitive dysfunction experienced by some patients. In this study we examined the
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effects of propofol anesthesia on each one of stages of the postnatal neurogenesis in the
dentate gyrus of young and aged rats.

Material and Methods
Animals: all experiments were conducted in accordance with the National
Institute of Health Guide and Use of Laboratory Animals, and were approved by the
Institutional Animal Care and Use committee of the University of South Florida, College
of Medicine. Male Fisher 344 (F344) rats (Harlan Sprague Dawley, Indianapolis, IN),
were pair-housed in environmentally controlled conditions (12:12h light: dark cycle at
21±1°C) and provided food and water ad lib. Two age groups of animals young (3
months-old) and aged (20 months-old) were used in this study. Animals were excluded
from the study if they became jaundiced, or had pituitary tumors.
Experimental timeline: three different thymidine analogs (CldU, IdU, and EdU)
were intraperitoneally injected at three different time points (21 days, 8 days, and 4 days,
respectively) prior to the anesthetic or control infusion in order to assessed integration,
maturation and differentiation of nascent cells in the dentate gyrus (DG) at the time of
propofol anesthesia. Moreover, phenotype identification at each time point was assessed
by co-localization of each thymidine analog with the corresponding histological marker
for each neurogenic stage. Quantification of co-localization of CldU and the mature
neuronal marker NeuN or the astrocytic marker S100β assessed nascent cells undergoing
synaptic integration at the time of propofol anesthesia. Quantification of co-expression of
IdU and the immature neuronal marker DCX or the astrocytic marker S100β assessed
nascent cells undergoing migration and axon/dendrite targeting.
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Furthermore, by

determining co-localization of EdU with the immature neuronal marker DCX or the
astrocytic marker S100β nascent cells undergoing differentiation were assessed. Lastly,
nascent cells proliferation was assessed using the endogenous marker Ki67. Labeling of
each neurogenic stage was performed in the same animal (Figure 16).
Preparation and administration of thymidine analogs: solutions of 5-Chloro2’-deoxyuridine (CldU) and 5-Iodo-2’-Deoxyuridine (IdU) were prepared at equimolar
concentrations. CldU (Sigma #C6891) was prepared at 17 mg/ml and IdU (MP#100357)
at 23 mg/ml. Injections at 2.5 ml/Kg resulted in an equimolar final effective delivery of
42.5 mg/Kg CldU or 57.5 mg/Kg IdU, as previously described (Vega and Peterson 2005).
Both halogenated thymidine analog solutions were prepared in sterile saline and
administered by intraperitoneal (IP) injection to ensure precise delivery to facilitate
quantitative comparisons. Because cell division is a rare event in the subgranular zone of
elderly rats and because many of these newborn cells do not survive, we were concerned
that a short thymidine analog labeling protocol would not yield a new cell number
sufficient for a meaningful analysis. Therefore, three times the thymidine analog
corresponding to a specific time point was administered; three IP injections at 4-hour
intervals in one day were given. As shown in Figure 16, animals in all groups were
injected with CldU, 21 days before intralipid or propofol infusion; and IdU, 8 days before
intralipid or propofol infusion.
A solution of 5-ethynyl-2’-deoxyuridine (EdU) was prepared at a concentration of
60 mg/ml in sterile saline. IP injections of EdU (cat #. E10187, Invitrogen, Carlsbad, CA)
resulted in a final effective delivery of 160 mg/Kg. Due to money constrains, animals in
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all groups were injected only once with EdU, 4 days before intralipid or propofol infusion
(Figure 16).
Propofol anesthesia: a cohort of rats was randomly assigned to four different
groups breathing air (n=10 per group): young rats that received 35 mg/kg/hr of propofol
or 10% intralipid (control) for 3 hrs, and aged rats that received 35 mg/kg/hr of propofol
or 10% intralipid for 3 hours. Unanesthetized rats were placed in a restrainer and a tail
vein catheter was implanted and attached to a syringe pump (model 11 Plus; Harvard
Apparatus). Propofol (Disoprivan; AstraZeneca) or 10 % intralipid (Fresenius Kabi;
Sweden) that served as control was continuously administered for 3 hours. Body
temperature of rats was maintained at 37°C with a thermostatically controlled heating
pad.
Measurement of Perioperiative Parameters during propofol anesthesia: rectal
temperature was monitored using a thermalet-monitoring thermometer (Physitemp
instrument Inc, Clifton, NJ, USA). Moreover, hemoglobin oxygen saturation (SpO2) and
heart rate (HR) were recorded during anesthesia period using the SurgiVet multi
parameter monitor (Smiths medical, Dublin, OH, USA). Diastolic, systolic and mean
arterial pressures were measured every 30 minutes throughout the anesthesia period by
tail cuff using the CODA non- invasive blood pressure system for rats (CODA2, Kent
Scientific Corporation).
Tissue collection and processing: twenty-four hours after intralipid or propofol
infusion, rats were deeply anesthetized with pentobarbital (50 mg/ Kg, i.p) and
transcardially perfused with 100 ml saline followed by ice-cold 4% paraformaldehyde in
0.1M PBS. Brains were removed, postfixed in the same fixative solution at 4°C
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overnight, transferred to 20% sucrose in PBS until equilibrated, and then embedded in
Tissue-Tek OCT before cryostat sectioning. Sagittal cryosections (30 µm thick) through
the entire DG were collected serially, transferred to a cryoprotectant solution, and stored
at -20°C until used. These sections were used to assess proliferation and phenotypic
determination of nascent cells in the DG. All standard staining procedures were
conducted on free-floating sections using every twelfth section for the entire
hippocampus beginning with a random start and including sections before and after the
hippocampus to ensure that the entire structure was sampled.
CldU and IdU Immunohistochemistry: for immunohistochemistry sections
were washed three times for 10 min in PBS before being treated with 0.2N HCL for 10
min at 37°C for DNA denature to facilitate antibody access, sections were then washed
with borate buffer (pH 8.5), followed by three washes of PBS. Sections were then
incubated in 5% normal goat serum and 0.25% Triton X-100 in PBS (PBS-TS) for 60
min, and stained at 4°C. Detection of halogenated thymidine analogs was accomplished
using rat anti-BrdU (Accurate cat# OBT-0030; clone BU1/75) at 1:250 for CldU and
mouse anti-BrdU (Becton Dickinson cat# 347580; clone B44) at 1:500 for IdU. All
secondary antibodies were used at 1:300 and were conjugated to the fluorophore
Alexa594.
EdU labeling protocol: EdU labeling was performed using Click-iTTM EdU
imaging kit cat # C10339 (Invitrogen, Carlsbad, CA) according to the manufacturer’s
protocol. This protocol is normally intended for use in cell culture, but it was adapted for
histological staining of brain tissue. Sagittal cryosections (30 µm thick) were washed
three times for 10 min in PBS. After washing twice with 3% bovine serum albumin
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(BSA) in PBS the sections were permeablized with 0.5% Triton X-100 in PBS for 20
min. The sections were washed twice with 3% BSA in PBS and then incubated with the
Click-iTTM reaction buffer, CuSO4, Alexa Fluor 594 Azide, and the reaction buffer
additive for 30 min while protected from light. The sections were washed one more time
with 3% BSA in PBS. Sections were then mounted onto glass slides, and coverslipped
with Vectashield mounting medium for fluorescence (cat# H-1000 Vector Laboratories,
Burlingame, CA, USA).
Double immunohistochemistry for lineage markers: the phenotypes of CldU,
IdU and EdU labeled cells were determined using double immunofluorescent staining.
Antibodies against DCX, NeuN and S100β were used to detect immature neurons, mature
neurons and astrocytes, respectively. DNA denaturation, followed by incubation of the
primary antibodies for CldU and IdU was performed as described above, together with a
rabbit polyclonal goat antibody raised against human DCX (1:200 cat# 4604 Cell
Signaling technology, Inc. Danvers, MA, USA) was used in an antibody cocktail with the
IdU antibody, a mouse monoclonal antibody against neuronal nuclei, NeuN (MAB377
Millipore, Billerica, MA, USA) was used at a concentration of 1:500 in an antibody
cocktail with the CldU antibody, and a rabbit monoclonal goat antibody raised against
S100β (ab52642 abcam, Cambridge, MA, USA) was used at a concentration of 1:3000 in
an antibody cocktail with CldU and IdU.
For double labeling of EdU/DCX and EdU/S100β EdU staining was performed
first, followed by incubation in with a rabbit polyclonal goat antibody against human
DCX or in and a rabbit monoclonal goat antibody against S100β, respectively.
Ki67 Immunohistochemistry: Ki67 is expressed in cells G1 through M phase of
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the cell cycle(Scholzen and Gerdes 2000). For detection of Ki67, sections were pretreated
with 1X Saline-Sodium Citrate (SSC) at 80°C for 40 minutes. Subsequently, endogenous
peroxidase activity was quenched with 0.6% H2O2 solution in PBS for 20 min. Sections
were blocked for 1 hour in 2% normal goat serum and 0.25% Triton X-100 in PBS (PBSTS). Sections were incubated overnight at 4°C with a rabbit polyclonal antibody against
human Ki67 (NCL-Ki67p; Novocastra Laboratories/Vision BioSystems, Newcastle upon
Tyne, UK) at a dilution of 1:2000 in PBS-TS. The following day, sections were washed
in PBS, incubated for one hour in biotinylated secondary antibody (goat anti-rabbit IgG
rat adsorbed 1:1000; BA-1000 Vector Laboratories, Burlingame, CA) in PBS-TS, and
washed in PBS before incubation for 1 hour in avidin-biotin substrate (ABC kit cat no.
PK-6100, Vector Laboratories, Burlingame, CA). Sections were washed in PBS for 10
minutes and reacted with 3,3´- diaminobenzidine tetrahydrochloride (DAB) solution (cat
no.1856090, Thermo Scientific, Rockford, IL). Sections were then mounted onto glass
slides, dehydrated, and coverslipped with mounting medium (Cytoseal 60,Stephens
Scientific, Riverdale).
Tunel assay protocol: in order identify which of the labeled cells were dying, the
in situ cell death detection kit, Fluorescein (cat no. 11684795910, Roche, Mannheim,
Germany) was used according to the manufacturer's instructions. Sections were incubated
with 3% bovine serum albumin in 0.1 mol/L Tris-HCL (pH 7.5) for 30 mins followed by
50 µL of TUNEL reaction mixture on each sample for 60 mins at 37°C. After washing,
slides were incubated with 0.3% H2O2 in methanol for 10 mins, followed by 3% bovine
serum albumin in 0.1 mol/L Tris-HCL (pH 7.5) for 30 mins at room temperature.
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Incubation with peroxidase-conjugated anti-fluorescein (diluted 1:5) at 37°C for 30 mins
was performed.
Microscopy and cell counting: unbiased stereological methods were used to
estimate the numbers of positive labeled cells (+labeled cells) in the subgranular zone of
the DG. Twelve equally spaced sections throughout the medial-lateral extent of the DG
were collected. Because +labeled cells are a rare event, the number of +labeled cells in
each DG examined was summed for individual animals and the sum from each animal
was then multiplied by the section spacing to estimate the total number of +labeled cells
(Mouton 2002)These data were then used to calculate group means for estimates of total
+labeled cells. Labeled cells that were greater than 1 cell diameter away from the
subgranular layer were not included in the count
Sections were imaged on an Olympus FV1000 MPE multiphoton laser scanning
microscope with four laser sources: 405 Diode, multi-line Argon (for Alexa 488), green
HeNe (for Alexa 594), and red HeNe was used for all immunofluorescence
photomicrographs. When quantification of percentage of positive cells was determined, Z
stacks were created at 1 µm intervals throughout the 30 µm of the sections with a guard
region of 2µm excluded form top and bottom of the Z stack. The Z stacks were rotated in
all planes to verify double labeling. Images of positive staining were adjusted to make
optimal use of the dynamic range of detection.
Statistical analyses: data are presented as mean ± SEM. Analysis of variance
(ANOVA) with Tukeys post hoc or a t-test was used to compare the differences from the
control group. P-values less than 0.05 were considered statistically significant, the
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significant testing was one-tailed and GraphPad Prism version 5.00 for Mac (GraphPad
Software, San Diego California USA, www.graphpad.com) was used to analyze the data.

Results
Physiological parameter during propofol anesthesia: rectal temperature was
recorded every 30 mins after propofol induction in young (n=8) and aged (n=8) rats.
Temperature was stable through the anesthesia period in both young and aged rats, with
temperature in the aged rats being approximately 1°C less than in young rats. Systolic,
diastolic and mean arterial blood pressure (mmHg) were recorded every 30 mins after
propofol induction in young and aged rats. The blood pressure was stable during the
exposure with a small decline in the aged rats as compared to the young rats. Moreover,
hemoglobin oxygen saturation and heart rate were also recorded every 30 minutes after
propofol induction in young and aged rats. Data are shown as mean ± SEM (Figure 17).
Postnatal proliferation in the Dentate Gyrus, as assessed by the Ki67 marker,
is unaffected by propofol exposure: the effects of propofol anesthesia (35 mg/Kg/hr for 3
hours) on neuronal cell proliferation in the SGZ in young (3 month old) and aged (20 month-old)
F344 rats was determined by analyzing Ki-67 labeling, 24 hours after exposure. Figure 18B
shows that Ki67 positive cells in both young and aged rats were primarily located on the border
of the granule cell layer. Propofol does not appear to have an effect on newborn cells generated
during the 24 hours after exposure (Figure 18A). The results were subjected to a 2 (age: young,
aged) X 2 (treatment: control, propofol) factorial ANOVA. There was a significant effect of age
(F (3, 7) = 28.93, p <0.0001), but no significant effect of treatment (F (3, 7) = 0.98, p = 0.47).
Propofol anesthesia did not result in a statistically significant effect in the young (p= 0.130) nor in
the aged rats (p=0.400).
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Nascent cells undergoing differentiation in the DG of young, but not aged
rats, are affected by propofol anesthesia: we look at the number of newborn cells
undergoing differentiation at the time of propofol infusion by estimating the number of
EdU positive cells. And determined the phenotype of these newly born cells using double
labeling of EdU and the immature neuronal marker DCX (Figure 19C) and EdU and the
astrocytic marker S100β (Figure 19A-B). The results were subject to a 2 (age: young,
aged) X 2 (treatment: intralipid, propofol) factorial ANOVA. There was a significant
effect of age (F (2,11)= 16.61, p<0.0001), and a significant effect of treatment (F (2,11)=
6.61, p< 0.05). Propofol anesthesia resulted in a statistically significant decrease in the
number of EdU+ cells (*p=0.034), in the number of EdU+/DCX+ cells (**p=0.023), but
not in the number of EdU+/S100B cells (***p=0.260)
Nascent cells undergoing migration in the DG are altered by propofol
anesthesia in young, but not in aged rats: we counted at the number of newborn cells
undergoing migration at the time of the propofol, anesthesia by estimating the number of
IdU positive cells. And determined the phenotype of these newly born cells using double
labeling of IdU and the immature neuronal marker DCX (Figure 20C) and IdU and the
astrocytic marker S100β (Figure 20D). The results were subject to a 2 (age: young, aged)
X 2 (treatment: intralipid, propofol) factorial ANOVA. There was a significant effect of
age (F (7,11)= 73.02, p<0.0001), and a significant effect of treatment (F (7,11)= 1.47,
p<0.05). Propofol significantly decreased the number of IdU+ cells (*p=0.034),
IdU+/DCX+ cells (**p=0.047), and increased the number of IdU+/S100β+ cells
(***p<0.0001) in the DG of young, but not aged rats.
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Nascent cells undergoing maturation, in the DG of young and aged rats, are
unaffected by propofol anesthesia: we estimated the number of newborn cells
undergoing synaptic integration at the time of propofol exposure by estimating the
number of CldU positive cells, and determined the phenotype of these newly born cells
(Figure 21A-B) using double labeling of: CldU and the mature neuronal marker NeuN
(Figure 21C), and CldU and the astrocytic marker S100β. There was a significant effect
of age (F (7,11)= 52.65, p<0.0001), but not a significant effect of treatment (F (7,11)= 1.94,
p=0.07).
Cell death in the DG after propofol anesthesia: cell death positive label in the
DG was assessed by the DNA strand breaks (TUNEL Assay) in young and aged rats 24
hours after propofol anesthesia (Figure 22). The results were subject to a 2 (age: young,
aged) X 2 (treatment: intralipid, propofol) factorial ANOVA. There was not s significant
effect of age (F (2,3)= 3.53, p=0.08), and no significant effect of treatment (F (2,3)= 0.42,
p=0.67). Propofol anesthesia did not result in a statistically significant effect in the young
(p=0.19) nor in the aged rats (p=0.12).

Discussion
The findings of this study are: first, the expected age-related decrease in the rate
of postnatal neurogenesis in aged as compared to young rats. Second, the age-dependent
effects of propofol on the young, but not on the aged rat brain. Third, the stage-dependent
effect of propofol, on nascent cells undergoing differentiation, migration and
axon/dendrite targeting, but not on nascent cells undergoing maturation and synaptic
integration. And lastly, it was found that the cognitive dysfunction experienced by some
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patients after anesthesia and which may be explained by an anesthetic-induced alteration
of postnatal neurogenesis appears to be agent-dependent, with isoflurane being
particularly harmful to the aged brain, and propofol being particularly harmful to the
young brain.
Propofol anesthesia has a specific effect on the young brain: human and
animal data suggest that propofol is harmful to developing neurons in the young brain
that result in cognitive sequelae (Takamatsu et al. 2005; Vutskits 2005; Mellon et al.
2007; Meyer et al. 2010). A study that examines neurogenesis as an explanation for
cognitive dysfunction, did not find and impairment of cognitive function in eighteenmonth old rats exposed to two hours of propofol anesthesia (Lee et al. 2008). However,
they did not examine the effect of propofol on the entire process of postnatal
neurogenesis. In this study, it was found that propofol particularly affects nascent cells in
the DG of young rats, but not aged rats. The neurogenic niche is regulated by signaling
from growth factors, trophic factors and neurotransmitters among others (Palmer et al.
2000; Taupin 2006), during development many of these signals are altered, and the
neurogenic process itself its occurring at a higher rate. For all this and more, the young
brain is particularly vulnerable to insults, in this case particularly vulnerable to anesthetic
toxicity.
Nascent cells undergoing differentiation and migration, in the DG of young
rats, at the time of anesthetic exposure are particularly affected by propofol:
evidence suggesting that propofol may be toxic to developing neurons (Spahr-Schopfer et
al. 2000; Fredriksson et al. 2007), and increasing clinical and laboratory data suggest an
anesthetic induced impairment of cognitive function (Loepke and Soriano 2008) is
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currently raising concerns in pediatric anesthesia. A study of the effects of propofol on
neuronal structure and neurocognitive performance in mice suggests that propofol
increases neurodegeneration, leading to adult, behavioral, and learning impairment in a
dose dependent manner (Fredriksson et al. 2007). Moreover, an in vitro study of neuronal
cell cultures from immature chicks and rats showed that supraclinical doses of propofol
induce neuronal cell death in dissociated cell culture models, but it fails to demonstrate
neurotoxic effects in organotypic slice culture (Spahr-Schopfer et al. 2000). Even though,
no prospective studies have examined the propofol effects on neuronal structure and
neurocognitive outcome in children, several case reports detail short-term neurological
abnormalities. In this study, a similar effect of propofol on the brain of young rats was
found. This effect was found to be specific to the nascent cells undergoing the first stages
of postnatal neurogenesis suggesting a specific susceptibility of immature nascent cells in
the DG.
Nascent cells in the DG of young and aged rats seem to be affected by
anesthetics in agent-dependent manner: this study shows that a anesthetic, i.e.
propofol, produces cognitive effects on one age population, i.e. young, whereas the other
does not, i.e. isoflurane, as previously reported. The most obvious explanation is these
two anesthetics have different receptor mechanisms of action. Propofol inhibits synaptic
transmission primarily by enhancing GABA receptors while having smaller effects on
NMDA receptors. On the other hand, isoflurane acts less selectively on GABA and
NMDA receptors. These differences in affinity for specific receptors are also associated
with differences in hippocampal electrophysiology, with isoflurane blocking induction of
long-term potentiation (LTP) and long-term depression (LTD) (Stevens 1998), while
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propofol only partially inhibits LTP and has no effect on LTD (Nagashima et al. 2005).
Consequently, it appears that there are important functional differences among
anesthetics with respect to memory process. Due to these inherent differences in the
molecular actions, not all agents that produce general anesthesia result in cognitive
impairments.
In conclusion, these results add to the growing body of evidence indicating that
exposure to general anesthetics early and late in life cause cognitive dysfunction, and
suggest that vulnerability to these deleterious effects may be age and agent dependent.

88

References

Al-Jahdari WS, Saito S, Nakano T, Goto F (2006) Propofol induces growth cone collapse
and neurite retractions in chick explant culture. Can J Anaesth 53: 1078-1085
Coras R, Siebzehnrubl FA, Pauli E, Huttner HB, Njunting M, Kobow K, Villmann C,
Hahnen E, Neuhuber W, Weigel D, Buchfelder M, Stefan H, Beck H, Steindler
DA, Blumcke I (2010) Low proliferation and differentiation capacities of adult
hippocampal stem cells correlate with memory dysfunction in humans. Brain 133:
3359-3372
Dupret D, Revest JM, Koehl M, Ichas F, De Giorgi F, Costet P, Abrous DN, Piazza PV
(2008) Spatial relational memory requires hippocampal adult neurogenesis. PLoS
One 3: e1959
Fredriksson A, Ponten E, Gordh T, Eriksson P (2007) Neonatal exposure to a
combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A
receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent
behavioral deficits. Anesthesiology 107: 427-436
Honegger P, Matthieu JM (1996) Selective toxicity of the general anesthetic propofol for
GABAergic neurons in rat brain cell cultures. J Neurosci Res 45: 631-636
Kempermann G (2002) Why new neurons? Possible functions for adult hippocampal
neurogenesis. J Neurosci 22: 635-638
Lee IH, Culley DJ, Baxter MG, Xie Z, Tanzi RE, Crosby G (2008) Spatial memory is
intact in aged rats after propofol anesthesia. Anesth Analg 107: 1211-1215
Loepke AW, Soriano SG (2008) An assessment of the effects of general anesthetics on
developing brain structure and neurocognitive function. Anesth Analg 106: 16811707
Mellon RD, Simone AF, Rappaport BA (2007) Use of anesthetic agents in neonates and
young children. Anesth Analg 104: 509-520

89

Meyer P, Langlois C, Soete S, Leydet J, Echenne B, Rivier F, Bonafe A, Roubertie A
(2010) Unexpected neurological sequelae following propofol anesthesia in
infants: Three case reports. Brain Dev 32: 872-878
Mouton PR (2002) Principles and Practices of Unbiased Stereology: An introduction for
bioscientistss. The Johns Hopkins University Press, Baltimore, Maryland
Nagashima K, Zorumski CF, Izumi Y (2005) Propofol inhibits long-term potentiation but
not long-term depression in rat hippocampal slices. Anesthesiology 103: 318-326
Palmer TD, Willhoite AR, Gage FH (2000) Vascular niche for adult hippocampal
neurogenesis. J Comp Neurol 425: 479-494
Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell
Physiol 182: 311-322
Spahr-Schopfer I, Vutskits L, Toni N, Buchs PA, Parisi L, Muller D (2000) Differential
neurotoxic effects of propofol on dissociated cortical cells and organotypic
hippocampal cultures. Anesthesiology 92: 1408-1417
Stevens CF (1998) A million dollar question: does LTP = memory? Neuron 20: 1-2
Takamatsu I, Sekiguchi M, Wada K, Sato T, Ozaki M (2005) Propofol-mediated
impairment of CA1 long-term potentiation in mouse hippocampal slices. Neurosci
Lett 389: 129-132
Taupin P (2006) Adult neural stem cells, neurogenic niches, and cellular therapy. Stem
Cell Rev 2: 213-219
Vega CJ, Peterson DA (2005) Stem cell proliferative history in tissue revealed by
temporal halogenated thymidine analog discrimination. Nat Methods 2: 167-169
Vutskits GE, Tassony E, Kiss JZ (2005) Clinically relevant concentrations of propofol
but not midazolam alter in vitro dendritic development of isolated gammaaminobutyric acid-positive interneurons. Anesthesiology 102: 970-976

90

Figure 16. Experimental design. Rats in all groups were injected 21, 8, and 4
days before propofol exposure, with CldU, IdU and EdU respectively. In order to study
the effects of propofol on integration, maturation and differentiation of neuronal cell
proliferation in the DG of young and aged rats
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Figure 17. Rats Physiological Parameters during Propofol Exposure (A)
Rectal temperature was recorded every 30 mins after propofol induction in young (n=8)
and aged (n=8) rats. Temperature was stable through the anesthesia period in both young
and aged rats, with temperature in the aged rats being approximately 1°C less than in
young rats. (B) Systolic, diastolic and mean arterial blood pressure (mmHg) were
recorded every 30 mins after propofol induction in young and aged rats. The blood
pressure was stable during the exposure with a small decline in the aged rats as compared
to the young rats. (C) Hemoglobin oxygen saturation and heart rate were also recorded
every 30 minutes after propofol induction in young and aged rats. Data are shown as
mean ± SEM.

92

Figure 18. Neural Progenitor Cell Proliferation is Unaffected by Propofol
Anesthesia (A) Shows the estimated number of Ki67 positive cells in the DG 24 hours
after propofol anesthesia in young and aged rats. The results were subjected to a 2 (age:
young, aged) X 2 (treatment: control, propofol) factorial ANOVA. There was a
significant effect of age (F (3, 7) = 28.93, p <0.0001), but no significant effect of
treatment (F (3, 7) = 0.98, p = 0.47). Propofol anesthesia did not result in a statistically
significant effect in the young (p= 0.130) nor in the aged rats (p=0.400). (B)
Immunohistochemical staining for Ki67 positive cells (20X, upper image) and (40X,
lower image) in DG 24 hours after propofol exposure in young and aged rats.
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Figure 19. The
number and fate of 4
days-old nascent
cells in the DG are
altered by propofol
anesthesia in young,
but not in aged rats
(A and B)
(A) Quantification of
EdU+ cells (right
column), EdU+/DCX+
cells (middle column),
and EdU+/S100β+
cells (left column) in
the DG of young rats
after propofol. (B)
Quantification of
EdU+ cells (right
column), EdU+/DCX+
cells (middle column),
and EdU+/S100β+
cells (left column) in
the DG of aged rats
after propofol. The
results were subject to
a 2 (age: young, aged)
X 2 (treatment:
intralipid, propofol)
factorial ANOVA.
There was a
significant effect of
age (F (2,11)= 16.61,
p<0.0001), and a
significant effect of
treatment (F (2,11)= 6.61, p< 0.05). Propofol anesthesia resulted in a statistically
significant decrease in the number of EdU+ cells (*p=0.034), in the number of
EdU+/DCX+ cells (**p=0.023), but not in the number of EdU+/S100B cells (p=0.260)
(C) Confocal plane of the same cell, showing co-localization of EdU+ (red), DCX+
(green) and EdU+/DCX+ (orange) indicating differentiation into neuronal phenotype.
Newly formed double-labeled cells were visualized using concofal microscopy in an
orthogonal projection composed of 25 optical z-planes (0.5mm thick).
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Figure 20. Cells undergoing maturation in the DG at 8 days after birth are altered by
propofol anesthesia in young, but not in aged rats. (A and B). Quantification of IdU+ cells
(right column), IdU+/DCX+ cells (middle column), and IdU+/S100β+ cells (left column) in the
DG of young rats (A) and aged rats (B) after propofol. The results were subject to a 2 (age:
young, aged) X 2 (treatment: intralipid, propofol) factorial ANOVA. There was a significant
effect of age (F (7,11)= 73.02, p<0.0001), and a significant effect of treatment (F (7,11)= 1.47,
p<0.05). Propofol significantly decreased the number of IdU+ cells (*p=0.034), and IdU+/DCX+
cells (**p=0.047), but increased IdU+/S100β+ cells (***p<0.0001) in the DG of young, but not
aged rats (C) Confocal plane of the same cells, showing co-localization of IdU+ (red), DCX+
(green) and IdU+/DCX+ (orange) indicating neuronal phenotype. (D) Confocal plane of the same
cell, showing co-localization of IdU+ (red), S100β+ (green) and IdU+/S100β+ (orange)
indicating astrocytic phenotype. Double-labeled cells were visualized using concofal microscopy
in an orthogonal projection composed of 25 optical z-planes (0.5mm thick).
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Figure 21. Propofol anesthesia does not alter nascent cells that underwent
maturation and Starting to integrate in the DG of young or aged rats Quantification
of CldU+ cells (right column), CldU+/NeuN+ cells (middle column), and CldU+/S100β+
cells (left column) in the DG of young (A) and aged (B) rats after propofol. The results
were subject to a 2 (age: young, aged) X 2 (treatment: intralipid, propofol) factorial
ANOVA. There was a significant effect of age (F (7,11)= 52.65, p<0.0001), but not a
significant effect of treatment (F (7,11)= 1.94, p=0.07). (C) Confocal plane of the same
cell, showing co-localization of CldU+ (green), NeuN+ (red) and CldU+/NeuN+ (orange)
indicating neuronal phenotype. Newly formed double-labeled cells undergoing
integration were visualized using concofal microscopy in an orthogonal projection
composed of 25 optical z-planes (0.5mm thick).
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Figure 22. Cell death in the DG after propofol anesthesia. Quantification of
the TUNEL+ labeling in the DG of young and aged rats, 24 hours after propofol.
Propofol anesthesia has no effect on cell death in the DG of young or aged rats. The
results were subject to a 2 (age: young, aged) X 2 (treatment: intralipid, propofol)
factorial ANOVA. There was not s significant effect of age (F (2,3)= 3.53, p=0.08), and
no significant effect of treatment (F (2,3)= 0.42, p=0.67). Propofol anesthesia did not result
in a statistically significant effect in the young (p=0.19) nor in the aged rats (p=0.12).
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CONCLUSIONS:
ANESTHETIC-INDUCED ALTERATION OF POSTNATAL NEUROGENESIS, A
POSSIBLE CAUSE OF THE COGNITIVE DYSFUNCTION OBSERVED IN
SOME PEDIATRIC AND GERIATRIC PATIENTS

Introduction
The use of general anesthetics involving millions of pediatric and geriatric
patients is widespread today. Emerging, clinical and laboratory findings suggest that
general anesthesia early or late in life may cause impairment of cognitive function, the
mechanism of which is still unknown (Dodds and Allison 1998; Culley et al. 2003;
Stratmann 2006; Loepke and Soriano 2008). Because cognitive function is in part
dependent on postnatal neurogenesis (Shors et al. 2001; Snyder et al. 2005; Coras et al.
2010). It is reasonable to infer that an anesthetic-induced alteration of postnatal
neurogenesis may, in part, explain the cognitive impairment observed after anesthesia in
pediatric and geriatric patients. This dissertation discusses the effects of two different
kinds of general anesthetics, isoflurane and propofol, on postnatal neurogenesis. First, it
focuses on their effects on the entire process of postnatal neurogenesis. Second, it
examines these effects on the two populations that seem to be more vulnerable to
anesthetic-induced cognitive impairment. Third, it studies two kinds of anesthetics that
are widely used, but have different mechanisms of action.
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The process of postnatal neurogenesis
One of the major objectives of this dissertation is to provide an analysis of the
effects of isoflurane and propofol anesthesia on the entire process of postnatal
neurogenesis, which is a complex process that involves multiple stages. Postnatal
neurogenesis is a multistep process that involves a series of developmental stages; the
final result is that few nascent cells are added to the existing hippocampal neuronal
circuitry. The neurogenic process starts with proliferation of the neural/stem progenitor
cells producing a pool of immature cells, the majority of which will become neurons if
they survive. The percentage of surviving neurons varies depending on the strain of
animal used; it can be as great as 75% or as little as 25% of the proliferating cells
(Kempermann et al., 1997c). Subsequently, nascent cells that had differentiated and
survived go through a migratory stage that occurs while the cells are becoming
functionally mature

(Kempermann

et

al.,

2003b).

Nascent

neurons

become

morphologically and physiologically fully mature 6 to 8 weeks after birth in the young
rodent (van Praag et al., 2002; Esposito et al., 2005; Zhao et al., 2006; Toni et al., 2008).
Alteration of one or more stages of postnatal neurogenesis may explain the
cognitive dysfunction observed in some pediatric and geriatric patients following general
anesthesia. Indeed in this dissertation, by examining the effects of isoflurane and propofol
on nascent cell number and phenotype at each developmental stage of neurogenesis an
anesthetic-induced alteration of one or more developmental stages was found. A
summary of the results is presented on figure 23. Cognitive function following anesthesia
was assessed in the first portion of this dissertation. However, emerging data show that
newly generated neurons in the dentate gyrus of the hippocampus play a significant role
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in spatial learning and memory, and that the reduction in the number of these cells
impairs cognitive function (Shors et al. 2001; Dupret et al. 2008; Zhao et al. 2008; Coras
et al. 2010). In addition, the role of postnatal neurogenesis in hippocampal dependent
learning and memory appears to be affected by different factors. For instance,
environmental enrichment (Kempermann et al. 1997) and exercise (van Praag et al. 1999)
results in increased neurogenesis. Conversely, stress (Mirescu et al. 2004), irradiation
(Tada et al. 2000; Mizumatsu et al. 2003) and age (Klempin and Kempermann 2007;
Shruster et al. 2010) decrease neurogenesis and impair different aspects of hippocampal
dependent memory (Dupret et al. 2008). For that reason, it is reasonable to hypothesize
that general anesthetics may have an effect on cognition.
Age-dependent vulnerability to anesthetic-induced cognitive dysfunction
Impairment of cognitive function in pediatric and geriatric patients who received
sedation or anesthesia has raised concern regarding their relevance and potential
implications for the practice of anesthesia. This dissertation particularly focuses on the
effects of anesthetics on these two populations. Previous studies suggest an agedependent vulnerability to the development of cognitive dysfunction following anesthesia
(Culley et al. 2003; Jevtovic-Todorovic et al. 2003; Culley et al. 2004; Stratmann 2006;
Meyer et al. 2010). Certainly, the data presented in this dissertation supports those
findings. The hippocampus appears to be particularly susceptible to general anesthetics,
during development and aging. Neurogenesis, gliogenesis and synaptogenesis occur at a
high rate during development. During aging there is a decline in cell proliferation in the
SGL, which is associated with decline in hippocampal-dependent spatial memory (Coras
et al. 2010). Despite an age-related reduction in the formation of new hippocampal
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neurons, the neurons that are added appear functionally equivalent to those in young
brain. This suggests, that neurogenesis in the aged brain is not aberrant, but simply down
regulated, with reduced cell proliferation and retarded neuronal maturation (Rao et al.
2005).
This dissertation examined the two previously mentioned age groups, because
they are the two populations that show cognitive decline. Moreover, neurogenesis
particularly in these two populations occurs at a different rate than in other populations.
During development and aging neurogenesis occurs at a higher and lower rate
respectively. In addition to the age-dependent effect suggested by the results on this
dissertation, an agent-dependent effect was also found. Isoflurane appears to be harmful
to the aged but not the young brain. On the other hand, propofol seems to be harmful to
the young but not the aged brain.
Agent-dependent effects on postnatal neurogenesis
The final objective of this dissertation was to identify the effects of two kinds of
general anesthetics. As reported here, one general anesthetic, isoflurane, produces cellular
effects in one age group, aged animals, while the other, propofol, does not. A possible
explanation is that these general anesthetics have different receptor mechanisms of
action. Isoflurane inhibits synaptic transmission in the central nervous system by acting
on various systems including those implicated in γ-aminobutyric acid (GABA), and Nmethyl-d-aspartate (NMDA) receptors (Orser et al. 1994; Solt and Forman 2007).
Propofol acts primarily by enhancing GABA, and having smaller effects on NMDA
receptors (Nishikawa and MacIver 2000). These differences in receptor affinity are also
associated with differences in hippocampal electrophysiology, with isoflurane blocking
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induction of long-term potentiation (LTP) and long-term depression (LTD) (Stevens
1998), while propofol only partially inhibits LTP and has no effect on LTD (Nagashima
et al. 2005).
Another factor, is the regulation of postnatal neurogenesis by neurotransmitters
(Ge et al. 2007). For instance, GABA causes depolarization of immature neurons
(Nagashima et al. 2005; Bordey 2006; Platel et al. 2007). Moreover, GABA antagonism
increases proliferation of neural progenitor cells, whereas GABA agonism exhibits the
opposite effects (Tozuka et al. 2005). Interestingly, a lack of GABA induced
depolarization in newborn neurons leads to significant defects in their dendritic
development and synapse formation. Taken together, GABA-induced depolarization
promotes the differentiation, maturation, and functional integration of newly generated
cells in the postnatal dentate gyrus (DG). Similarly glutamate release from astrocytes and
neurons may activate the immature neuron receptors and regulate the development of
immature neurons (Montana et al. 2004). Moreover, recent studies of electrophysiology
have shown that newborn neurons in the DG begin to receive functional glutamatergic
inputs two weeks after they are born (Esposito et al 2005, GE et al 2006, Carleton et al
2003), and NMDA receptors antagonists have been shown to increase the number of new
immature neurons (Tashiro et al 2006). Thus, Glutamate has a direct regulatory role on
the stages of postnatal neurogenesis.
Consequently, GABA and NMDA signaling are neurogenic trophic factors and
excessive stimulation or under stimulation of them in the young or aged brain may cause
behavioral consequences by altering neural connectivity (Manent et al. 2007). So it
appears that there are important functional differences among anesthetics with respect to
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memory process, and due to these inherent differences in the molecular actions, not all
agents that produce general anesthesia result in cognitive impairment in a particular age
group
Conclusion
For many years, general anesthetics have been considered to be safe since there
were not reports indicating otherwise. However, emerging clinical and laboratory data
suggest that pediatric and geriatric patients are at risk of cognitive dysfunction following
general anesthesia. Current studies and this dissertation suggest that an anestheticinduced alteration of postnatal neurogenesis may result in later impairment of cognitive
function. Because neurogenesis is particularly vulnerable during developing and aging,
the two main affected groups are at the extremes of age. The use of anesthetics is a
necessity that cannot be avoided in pediatric and geriatric patients when life-threatening
conditions require surgery. Therefore, it is urgent that we improve our understanding of
the mechanisms underlying the cognitive function impairment induced by anesthetics.
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Figure 23. Summary diagram of the results presented in this dissertation
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